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 RÉSUMÉ 
Les récoltes de céréales sont souvent contaminées par des moisissures qui se développent 
pendant la récolte et l’entreposage et produisent des métabolites secondaires appelés 
mycotoxines. Le porc est reconnu pour être sensible au déoxynivalénol (DON). L’infection 
virale la plus importante chez le porc est causée  par le virus du syndrome reproducteur et 
respiratoire porcin (VSRRP).  Celui-ci provoque un syndrome grippal et des troubles de 
reproduction. L’objectif du présent projet était de déterminer l'effet in vitro de DON sur la 
réplication du VSRRP dans de lignées cellulaires permissives, MARC-145 et PAM, et 
déterminer in vivo l'impact de DON dans des aliments naturellement contaminés sur 
l’infection au VSRRP chez le porcelet. Tout d’abord, les cellules ont été incubées avec des 
doses croissantes de DON et ont été infectées avec du VSRRP pour évaluer la viabilité et la 
mortalité cellulaire, la réplication virale et l’expression de cytokines. Les résultats ont montré 
que les concentrations de DON de 560ng/ml et plus affectaient significativement la survie des 
cellules MARC-145 et PAM infectées par le VSRRP. En revanche, il y avait une 
augmentation significative de la viabilité et une réduction de la mortalité cellulaire à des 
concentrations de DON de 140 à 280 ng/ml pour les cellules PAM et de 70 à 280 ng/ml pour 
les cellules MARC-145 avec une réduction de l'effet cytopathique provoqué parle VSRRP. Au 
niveau in vivo, 30 porcelets divisés en 3 groupes de 10 porcelets et nourris pendant 2 semaines 
avec 3 différentes diètes naturellement ont été contaminées avec DON (0; 2,5 et 3,5 mg/kg). 
Les porcelets ont été subdivisés en 6 groupes, 3 groupes de 6 porcelets et ont été exposés au 
DON pendant 2 semaines et infectés par voie intratrachéale et intramusculaire avec le virus. 
Les 3 autres groupes de 4 porcelets servaient de contrôle non infectés. Les signes cliniques ont 
été enregistrés pendant 21 jours. La virémie a été évaluée par PCR. À la fin de 
l’expérimentation, les porcelets ont été euthanasiés et les lésions pulmonaires ont été évaluées. 
Les résultats ont montré que l’ingestion de DON à 3,5 mg/kg a augmenté l’effet du VSRRP 
sur la sévérité des signes cliniques, les lésions pulmonaires et la mortalité. L’ingestion de 
DON à 2,5 mg/kg a entrainé une augmentation de la virémie au jour 3 après l’infection mais 
sans impact sur les signes cliniques et les lésions pulmonaires.  
Mot clés: DON, VSRRP, MARC-145, PAM, effet cytopathique, cytokines, PCR 
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ABSTRACT 
Cereal crops are often contaminated with moulds that grow during harvest and storage and 
produce secondary metabolites called mycotoxins. Pig is known to be sensitive to 
deoxynivalenol (DON). On the other hand, infection by porcine reproductive and respiratory 
syndrome virus (PRRSV) causes a flu-like syndrome and reproductive disorders. The 
objectives of this project were to determine the in vitro effect of DON on the replication of 
PRRSV in permissive cell lines, MARC-145 and PAM and the in vivo impact of DON-
naturally contaminated feed on PRRSV infection in piglets. Firstly, cells were incubated with 
gradually increasing doses of DON and were infected with PRRSV to evaluate cytopathic 
effect and to assess cell viability, virus replication and cytokine mRNA expression on infected 
and uninfected cells. Results showed that DON concentrations of 560 ng/ml and higher were 
significantly detrimental to the survival of MARC-145 cells infected with PRRSV. In contrast, 
there was a significant increase of cell viability and decreased of cell mortality at DON 
concentrations within 140 to 280 ng/ml for PAM cells and 70 to 280 ng/ml ranges for MARC-
145 showing a reduced cytopathic effect (CPE) caused by PRRSV. 
In vivo study was carried out on 30 piglets divided into 3 groups of 10 piglets fed naturally 
contaminated diets with different levels of DON; 0, 2.5 and 3.5 mg/kg. After 2 weeks, pigs 
were further divided into 6 subgroups, 3 subgroups of 6 piglets were infected intra tracheally 
and intramuscularly with PRRSV. The other 3 subgroups of 4 piglets were used as uninfected 
controls. Clinical signs were recorded for 21 days post-infection (p.i.). Sera were evaluated for 
viremia by PCR. At the end of the experiment, piglets were euthanized and pulmonary lesions 
were evaluated. Results showed that ingestion of diet highly contaminated with DON at 3.5 
mg/kg increased the effect of PRRSV infection on the severity of clinical signs, weight loss, 
lung lesions and mortality. Diet with DON at 2.5 mg/kg showed an increase of viremia at day 
3 but had not significant impact on clinical signs and lung lesions. 
Keywords: DON, PRRSV, MARC-145, PAM, cytopathic effect, cytokines, PCR 
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Mycotoxins are secondary metabolites synthesized by moulds, which colonize plants 
in fields and/or during storage. The Food and Agriculture Organization (FAO) estimates that 
as much as 25 % of the world’s agricultural commodities are contaminated with mycotoxins to 
a certain degree. Among these mycotoxins, deoxynivalenol (DON), also known as vomitoxin, 
is produced by Fusarium fungi and plays an important role as a toxin for humans and farm 
animals around the world because it is frequently found at toxicologically relevant 
concentrations. Deoxynivalenol can contaminate several types of grains such as wheat, barley 
and corn since Fusarium colonization is an increasingly common problem as a result of the 
expanded use of “no-till farming” and changing climate patterns (McMullen et al., 1997).  
Pig diet is largely composed of grains, which represent the most important source of 
DON contamination. Reduced feed consumption and lower weight gain are the main clinical 
effects of the ingestion of DON-contaminated feeds. Moreover, DON has an 
immunomodulatory effect on pigs’ immune system depending on the concentration and 
duration of exposure; low concentrations of DON (1-2 mg/kg) are immunostimulatory while 
high concentrations (3-6 mg/kg) are immunosuppressive. While immunosuppression can be 
explained by the inhibition of the ribosome function and translation, immunostimulation can 
be related to interference with normal regulatory mechanisms such as suppression of normal 
immune response to pathogens apoptosis of macrophages and autoimmune-like effects which 
are similar to human IgA nephropathy (Pestka et al., 2004). Furthermore, DON rapidly 
activates mitogen-activated protein kinases (MAPKs) and induces cells’ apoptosis in a process 
known as ribotoxic stress response to cytotoxic interference (Iordanov et al.,  1997). 
Consequently, feeding pigs with DON-contaminated diets may result in impaired immune 
function and decreased resistance to infectious diseases. 
Swine industry faces many challenging diseases that have great financial impacts and 
pose a significant threat to the profitability. Among these diseases, porcine reproductive and 
respiratory syndrome (PRRS) is present worldwide. Since its emergence in late 1980s, PRRS 
has proven to be a persistent and insidious threat to the health and productivity of the US and 
Canadian swine herds (Neumann et al., 2005). The disease caused by the PRRS virus costs 
approximately $130 million per year to the Canadian swine industry (Mussell, 2010). This 
syndrome has many clinical manifestations in pigs at different physiological stages. In sows, it 
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is characterized by late-term abortions and an increased number of stillborn, mummified and 
weak born pigs. Piglets show respiratory problems and pneumonia (Rossow et al., 1994). In 
herds with multiple secondary diseases impacting production, co-infection with bacteria and 
viruses can exacerbate PRRS clinical signs. The virus of PRRS is known to infect a specific 
subset of pig macrophages that are mainly present in lungs; alveolar macrophages (Duan et al., 
1997).  
 Previous studies have shown that the immunosuppressive effects of DON decrease 
host resistance to infectious viral diseases. In mice infected with reovirus, consumption of 
DON exacerbated bronchopneumonia clinical signs (Li et al., 2007) and interfered with 
immune response after enteric infection (Li et al., 2005). Since DON is frequently encountered 
in pig diets, its presence could exacerbate viral infection by PRRSV. On the other hand, to the 
author’s knowledge, there is no in vitro model that can determine the impact of DON on 
PRRS infection at the cellular level. Therefore, the objectives of this study were (1) to 
evaluate in vitro effects of DON on the replication of PRRSV in two permissive cell lines, 
cells derived from monkey kidney cells (MARC-145) and porcine alveolar macrophages 
(PAMs) and (2) to evaluate in vivo impact of DON-naturally contaminated feed on PRRSV 
infection in pigs. 
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1. Mycotoxins 
1.1 Introduction 
Mycotoxins are toxic and carcinogenic secondary metabolites produced by various 
fungal species that colonize plants in agricultural commodities and during storage. Forages 
and cereals represent the most important contamination source of mycotoxins and the level of 
contamination depends on processed stages before and after the harvest of raw materials 
(Devegowda and Murty, 2005). Temperature and humidity are important in mycotoxins’ 
production; fungi grow at temperatures between 20 °C and 30 °C with a high relative humidity 
(70 to 90%) (Nielsen et al., 2004). These temperatures are beneficial to deoxynivalenol (DON) 
production by promoting growth and development of Fusarium graminearum (Miller, 2001). 
It is important to note that if the grain is harvested at a high temperature, it can maintain this 
temperature for several days or even weeks in a storage facility unless cooling equipment can 
be provided to avoid fungus growth (Wegulo, 2012). Under field conditions, stress 
predisposes plants to infestation and colonization by toxigenic fungi. Some species of these 
fungi are able to produce more than one mycotoxin; these include species of Claviceps, 
Neoitphodium, Fusarium, Alternaria, Cladosporium, Diplodia, Gibberella and 
Helminthosporium (Devegowda and Murty, 2005).  
Highest levels of mycotoxins are associated with insects and mites because they 
contribute to mould growth through physical damages of grain and by carrying mould spores. 
Their faecal material is an additional substrate for mould growth, which predisposes mould 
invasion of exposed endosperm (Munkvold and Desjardins, 1997). Also, metabolic activity 
produced by insects causes an increase in moisture migration, condensation, water leaks and 
fungal growth (Santin et al., 2005). 
 In stored grains, toxigenic fungal contamination and mycotoxin production result from 
a complex interaction between moisture, temperature and oxygen (O2) (Ominski et al., 1994). 
Although moulds are aerobic organisms that need O2 to grow normally, they can generally 
develop even when the O2 content is as low as ten percent of the normal atmospheric oxygen 
concentration. For example, Aspergillus flavus can grow in environments containing O2 
concentration of 0.5% (Keller et al., 1997).  
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Moisture content and ambient temperature are key determinants of fungal colonization 
and mycotoxin production. It is conventional to subdivide toxigenic fungi into “field” (plant-
pathogenic) or “storage” (saprophytic/spoilage) organisms (Santino, 2005). Field fungi are 
those that invade seeds while crops are still in the field and require high moisture conditions 
(20-21%); these include species such as Claviceps, Fusarium, Cladosporium, Diplodia, 
Gibberella and Helminthosporium. Storage fungi species such as Aspergillus and Penicillium 
invade grains or seeds and need lower moisture conditions (13-18%); usually, they do not 
present any serious problem before harvest (Santino, 2005).  
 To avoid mycotoxin accumulation in stored grains and oilseeds, moisture has to be 
controlled. If the product is too dry to allow fungal growth and if it is kept dry, no further 
deterioration will occur. However, if there is insect or rodent activity, moisture migration, 
condensation, or water leaks, fungal growth could lead to mycotoxin contamination (Patience 
and Ensley, 2010).  
1.2 Common mycotoxins in swine 
       1.2.1 Aflatoxins 
 Aflatoxins are produced primarily by a common fungus, Aspergillus flavus and closely 
related species A. parasiticus. These are well-defined species: A. flavus produces only B 
aflatoxins and A. parasiticus produces both B and G aflatoxins. Aflatoxin contamination is 
almost exclusively confined to tropical feeds in drought conditions; it is not produced in cold 
temperatures since high temperatures are needed for toxin synthesis (Sweeney & Dobson, 
1998). Among the four major types of aflatoxins, aflatoxin B1 (AFB1) is the most toxic and 
carcinogenic to animals but outbreaks occur mostly in pigs and cattle. Piglets are extremely 
sensitive to aflatoxins and susceptibility decreases with age (Dhanasekarani et al., 2011). 
Therefore, aflatoxicosis clinical signs depend on the species, age, concentration and duration 
of the exposure. Normally, sows and boars tolerate concentrations over 0.5 mg/kg in feed for 
short periods (3 to 5 days), but when sows are fed for extended periods (1 to 3 weeks), 
aflatoxins concentrations in the feed should not exceed 0.1 mg/kg (Dhanasekarani et al., 
2011). 
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 In pigs, ingestion of 1 to 5 mg/kg of AFB1 reduced growth and feed efficiency and 
animals died within 12-20 hours (Drabeket al., 1979). Chronic exposure at concentrations of 
0.1 to 0.5 mg/kg can result in suppressed immune response and decreased growth rate. The 
main target organ of aflatoxins is the liver. After aflatoxins’ invasion of the liver, lipids 
infiltrate hepatocytes which lead to hepatic centrilobular necrosis and bile duct hyperplasia 
(Weaveret al., 2013). The clinical syndrome in pigs includes depression, anorexia, decreased 
feed conversion and growth, weight loss, muscular weakness, bloody rectal discharge and 
icterus. At necropsy, livers of pigs that were fed toxic concentrations of AFB1 (0.5 mg/kg) 
vary in color from tan to pale yellow, are atrophied, and have abnormal amounts of fibrous 
connective tissue that is resistant to cutting (Dhanasekaran, 2011). 
1.2.2 Ochratoxins 
 Ochratoxins are secondary metabolites of Aspergillus (mainly A. ochraceus) and 
Penicillium (especially P. verrucosum and P. carbonations). Actually, the optimal temperature 
for ochratoxin synthesis by Aspergillus ochraceus is 28 °C, this synthesis being very low at 15 
°C or at 37 °C. However, Penicillium viridicatum develops and can produce ochratoxins at a 
range of temperatures between 4 and 30 °C (Marin et al., 2009). 
 While ochratoxins B and C are less important, the most prevalent is ochratoxin A 
(OTA) which is found in cereal grains such as wheat, corn, rye and barley, but can also be 
found in rice, soybeans, coffee, cacao, beans, peas, peanuts and dried fruits (Marin et al., 
2009). When pigs consume OTA over a long period of time, it can contaminate most of the 
edible tissues including organs, fat, muscle and blood. The main clinical symptoms of OTA 
include reduced growth rate and feed efficiency. Liver damage may occur, but the main effect 
is on the kidney, resulting in interstitial fibrosis. Increased water intake (polydipsia), and 
hence increased urine output (polyuria) are signs of this intoxication (Marin et al., 2009). 
Toxic effects of OTA in pigs depend on the concentration; for example, pigs fed 2.5 to 14 
mg/kg of OTA are severely depressed with severe diarrhea, emesis and fever. Dehydration 
occurs rapidly following polydipsia and polyuria. The most obvious damage caused by OTA is 
observed in the kidneys with strong degenerative changes in proximal tubules and fibrosis 
(Stoev et al., 2012; Szczech et al., 1973).  
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1.2.3 Trichothecenes 
 Trichothecenes represent a very large family of chemically-related mycotoxins 
produced by various species of Fusarium, Myrothecium, Trichoderma, Trichothecium, 
Cephalosporium, Verticimonosporium, and Stachybotrys. Trichothecenes are classified into 
four groups: A, B, C, and D. All trichothecenes share a common tricyclic skeleton with an 
epoxide function. Group A trichothecenes include T-2 toxin, HT-2 toxin and 
diacetoxyscirpenol (DAS). Group B trichothecenes include DON and its four derivatives: 3-
acetyl deoxynivalenol (3-ADON), 15-acetyl deoxynivalenol (15-ADON), DON-glucoside, and 
nivalenol (NIV). Group C includes compounds such as crotocine and group D includes 
compounds such as satratoxin G, but these two groups are less important than groups A and B 
(Figure 1 ) (Wu et al., 2010; Puri & Zhong, 2010). 
 The most essential structural features of trichothecenes affecting biological activities 
are: a) the double bond at C-9 and C-10 which is a basic requirement for toxic effects and 
biological activity for trichothecenes. The reduction of this double bond at C-9 and C-10 
results in a substantial decrease in activity and causes inhibition in protein synthesis of 
eukaryotic cells; b) the presence of the 12, 13-epoxide ring as a typical structure for 
trichothecene toxicity. Since the epoxide ring is necessary for disruption of protein synthesis, 
this plays a significant role in the inhibitory mechanism; c) the 5 variable R groups, the 
structure and position of a side chain, the presence of a second epoxy ring in type C members 
such as crotocine that have another epoxy group at C-7 and C-8 position; and d) compounds in 
type D, such as satratoxins and roridins include a macrocyclic ring at C-4 and C-15 (Wu et al., 
2013; Bräse et al., 2009). 
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Figure 1: Chemical structures of trichothecenes (Examples of groups A-D) adapted from Wu 
et al. (2010). 
1.2.3.1 Group A T-2 and HT-2 toxins 
 T-2 and HT-2 toxins are produced by fungi F. acuminatum, F. equiseti, F. poae, and F. 
sporotrichoides. They often occur together in infected cereals, which are commonly found in 
various cereal crops (wheat, maize, barley, oats, and rye) and processed grains (malt, beer and 
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bread) (Balzer et al., 2004). T-2 toxin is rapidly metabolised in the intestine and liver to HT-2 
toxin, which is the major in vivo metabolite. After ingestion by pigs and most other animal 
species, HT-2 toxin is rapidly absorbed and then distributed throughout the organism with 
very little accumulation in organs (Balzer et al., 2004). T-2 toxin at ≥ 0.6 mg/kg intravenous 
IV produced a large range of toxic effects in animals, especially in pigs, such as emesis, 
diarrhea, weight loss, lethargy, hemorrhage of lymph nodes and edema. Pathological changes 
in the stomach and liver have been reported along with necrosis and damage of cartilaginous 
tissues. (Li et al., 2011).  
 In pigs, acute effects of T-2 toxin occur after oral exposure at concentrations over 10-
16 mg/kg and produce non-specific symptoms such as weight loss, feed refusal and vomiting. 
Sub-chronic concentrations of ≥ 1 mg/kg reduced body weight gain (European commission, 
2001). 
1.2.3.2 Group A Diacetoxyscirpenol  
 Diacetoxyscirpenol (DAS) is a potent mycotoxin produced by certain Fusarium strains 
(F. equiseti, F. poae, F. acuminatum, F. sambucinum and F. sporotrichoides). A small amount 
is sufficient to cause toxicosis in pigs. Diacetoxyscirpenol has been found in unharvested corn, 
silage, soybeans, as well as in finished feeds using corn and soybeans as ingredients (Jacobsen 
et al., 2007). All domestic animals, including pigs, are susceptible to dietary poisoning at low 
concentrations: 1 to 3.5 mg/kg. Clinical signs produced by DAS in pigs are established as feed 
refusal and decrease in weight gain. Diacetoxyscirpenol is especially known to produce severe 
inflammation of the gastrointestinal tract and possible hemorrhage, accompanied with bouts of 
diarrhea, lethargy and abdominal pain (Jacobsen et al., 2007). 
1.2.3.3 Group B Deoxynivalenol (DON)  
 The occurrence of DON is associated primarily with Fusarium graminearum 
(Gibberella zeae) and F. culmorum. The exposure risk to animals is directly through foods of 
plant origin (cereal grains). It is found predominantly in grains such as wheat, barley, oats, rye, 
and maize. Deoxynivalenol plays an important role as a mycotoxin which affects farm animals 
in all parts of the world. Pigs are known to be especially susceptible to DON (Sobrova et al., 
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2010; Placinta et al., 1999). It induces feed refusal at concentrations of ≥ 2 to 3 mg/kg and 
produces emesis at 7 to 10 mg/kg. These two effects are probably linked because DON is 
transported to the brain, where it runs dopaminergic receptors and alters brain neurochemicals 
and the serotoninergic system which play roles in the mediation of feeding behaviour and 
emetic response (Rotter et al., 1996). 
1.2.3.4 Group B Acetyl DON (3-ADON) and 15-acetyl DON (15-ADON) 
 Fusarium graminearum strains produce two modified forms of DON called 3-ADON 
and 15-ADON. These trichothecenes are also detectable in cereals and differ by the presence 
of acetyl functions at C3 and C15 (Alexander et al., 2011). Surveys of naturally infected grain 
in the U.S. and Canada indicate that 3-ADON and 15-ADON are found only at low levels 
when high amounts of DON are present. However, it is not yet known if 3-ADON produces 
more DON in field-grown plants than 15-ADON (Mirocha et al., 1989). Concentrations of 15-
ADON as a DON precursor (50 to 75 mg/kg) in swine increased the emetic activity (Pestka et 
al., 1987). 
1.2.3.5 Group B DON-glucoside  
 Detoxification reactions in plant tissue involve sequestration of compounds conjugated 
to glucose which are produced in the cell wall into the vacuole and are excreted by root 
exudation. This way, DON-glucoside can be stored in plant vacuoles, where they are protected 
against cleavage by beta-glucosidases. These are enzymes which catalyze the transfer of 
glycosyl group between oxygen nucleophiles resulting in the hydrolysis of beta glycosidic 
linkage present between carbohydrate residues in aryl-amino or alkyl-beta-D-glucosides, and 
cyanogenic glucosides under physiological conditions, while synthesis of glycosyl bond 
between different molecules can occur by hydrolysis and transglycosylation (Singhania et al., 
2013; Berthiller et al., 2005). The trichothecene glucosides such as DON-3-glucoside and 
DON-15-glucoside have been obtained from Fusarium sulphureum cultures (Berthiller et al., 
2005). The capacity of several plants to transform DON by conjugation to glucose was 
demonstrated by Poppenberger et al., (2003) who isolated and characterized a cytoplasmatic 
UDP-glycosyltransferase from model plant of Arabibidopis thaliana capable of transforming 
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DON into DON-3-β-D-glucopyranoside (DON-3-glucoside), where the hydroxyl group in 
position C13 of DON is replaced by a glucose unit (Figure 2). 
 
 
Figure 2: Structure reaction of DON into DON-3-glucoside product (DOGT1: DON-
glycosyltransferase). Taken from Poppenberger et al (2003). 
1.2.3.6 Group B nivalenol 
 Nivalenol belongs to group B trichothecenes and is produced by Fusarium genus, 
Fusarium cerealis (F.crookwellence) and Fusarium poae and often co-occurs with DON. 
These fungi are abundant in various cereal crops such as wheat, maize, barley, oats and rye 
and processed grains like malt, beer and bread (Pettersson & Hedman, 1997). The capacity of 
NIV to produce clinical signs depends on the ingested concentration. Several countries have 
established regulation of NIV; concentrations between of 0.5 to 2 mg/kg produce no clinical 
signs in pigs. However NIV at 2.5 to 5 mg/kg of the diet caused vomiting and feed refusal. 
Pathological alterations in kidneys and the gastrointestinal tract have also been reported. 
Concentrations over 6 mg/kg have been described to cause feed refusal, decreased weight gain 
and increased serum alkaline phosphatase activity (Hedman et al., 1997). 
1.2.4 Zearalenone 
 Zearalenone (ZEA) is a non-steroidal estrogenic mycotoxin biosynthesized by a variety 
of Fusarium fungi, including F. graminearum (Gibberella zeae), F. culmorum, F. cerealis, F. 
equiseti, F. crookwellense and F. semitectum (Bennett and Klich, 2003). In Europe, corn is the 
cereal at risk with high incidence and high levels of contamination with ZEA (EFSA, 2011). 
 Deoxynivalenol                                      Deoxynivalenol-3-glucoside 
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In Canada, ZEA concentrations over 141 mg/kg were reported in corn and corn-based foods, 
as well as in wheat, barley and soybeans (Scott, 1997).  
 In pigs, ZEA is rapidly absorbed in the small intestine after oral administration. Indeed, 
over 85% of ZEA is absorbed by the intestinal lumen and can be found in the blood in less 
than 30 min. Once absorbed, enzymes such as CyP450 in small intestine epithelial cells and 
the liver can quickly convert ZEA into alpha zearalenol (α-ZOL), beta zearalenol (β-ZOL) and 
beta zearalanol (β-ZAL), the main metabolites which are subsequently conjugated with 
glucuronic acid (Kanora & Maes, 2013; Zinedine et al., 2007). In pigs, exposure to high 
concentrations of 20 mg/kg affects the prepubertal and cycling of young gilts which are more 
sensitive than pregnant sows. During pregnancy, ZEA reduces embryonic survival, decreases 
foetal weight, and may cause abortion. Moreover, ZEA causes alterations to the uterine 
environment by decreasing LH and progesterone secretion and by altering uterine morphology 
(Tiemann & Danicke, 2007). In gilts, concentration over 3 mg/kg induces low growth rate, 
alters nutrient availability and produces changes in genital organs, liver, as well as kidney 
functions. Histopathological changes suggest that ovaries are inflamed and 
hyperoestrogenized. Exposure to chronic concentration of 0.35 mg/kg for 35 days did not 
show any effect on uterus weight (EFSA, 2011; Doll et al., 2003). 
1.2.5 Fumonisins 
 Fumonisins were first isolated in South Africa in 1988 from cultures of Fusarium 
verticillioides, formerly Fusarium moniliforme, and F. proliferatum. Fumonisins’ mechanism 
of action appears to involve disruption of sphingolipid biosynthesis by the inhibition of 
ceramide synthase, modification of cellular proliferation through changes in cell cycle 
regulators, and increased expression of cytokines such as tumoral necrosis factor alpha 
(TNFα). There are two prevalent isoforms of fumonisins: fumonisin B1 (FB1) and B2 (FB2) 
(Colvin et al., 1993). 
1.2.5.1 Fumonisin B1 
 Fumonisin B1 commonly contaminates corn, wheat and other cereals worldwide. It is 
highly toxic for many farm animals including ducklings, horses, pigs, rats, and sheep. In pigs, 
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ingestion of dietary concentrations of 16 mg/kg results in pulmonary oedema with hydrothorax 
and concentrations over 200 mg/kg produce visible icterus by day 14 post-ingestion, with 
severe depression and anorexia. Lower concentrations of 1 to 10 mg/kg did not cause any 
clinical signs. At necropsy however, these concentrations produced evident pulmonary 
changes (Zomborszky-Kovacs et al., 2002). Histopathological examination demonstrated that 
FB1 is hepatotoxic and nephrotoxic in pigs. The earliest histological change to appear in either 
liver or kidney in fumonisin-treated animals is the increase of apoptosis followed by 
regenerative cell proliferation. In the liver, it produces hepatocellular degeneration and 
intermittent necrosis. Fumonisin B1 causes two diseases, which occur in horses and pigs with 
rapid onset: equine leukoencephalomalacia and porcine pulmonary oedema syndrome. Both of 
these diseases involve disturbed sphingolipid metabolism and cardiovascular dysfunction 
changes (Haschek et al., 2001; Fazekas et al., 1998). 
1.2.5.2 Fumonisin B2 
 Fumonisin B2 is produced by Fusarium verticillioides and Fusarium moniliforme and 
is more cytotoxic than FB1. It has been demonstrated that FB2 is carcinogenic. FB2 causes 
lesions to the liver, kidney and heart of pigs at dietary concentrations ≥ 58 mg/kg (Voss et al., 
2007).  
1.3 Deoxynivalenol and its toxicity  
1.3.1 Absorption, metabolism and elimination of DON 
In pigs, after consumption of contaminated feed, DON is rapidly and efficiently 
absorbed in the stomach and intestine. The majority of DON ingested from the diet is 
conjugated and de-epoxidated in the proximal small intestine by microbes, which have a major 
effect on the bioavailability of DON and its metabolites, where it induces epithelial damage 
and inflammatory response causing inhibition of nutrient absorption and compromising 
intestinal barrier function (Wache et al., 2009). Between 54 and 89 % of the ingested toxin is 
absorbed through the jejunum in large amounts and can cross the intestinal epithelium and 
reach the blood compartment. Deoxynivalenol is observed in the plasma after 30 min and its 
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serum concentration reaches a peak value within three to four hours post-ingestion  (Goyarts 
& Danicke, 2006; Eriksen et al., 2003). Deoxynivalenol can be detected very rapidly in other 
organs; for example, in the cerebral spinal fluid, DON is detected in less than 2.5 min 
following IV administration in pigs. When DON is administered IV, the affected organs are 
those that are the most perfused such as the lungs, myocardial muscle, kidneys and brain 
(Eriksen et al., 2003; Prelusky et al., 1990). 
 To characterize the pathophysiologic effect of DON, it is important to understand the 
integrity of the intestinal mucosa, which is the border between the organism and the 
environment. This is the first barrier for nutrients and potentially harmful substances such as 
mycotoxins (Fanning et al., 1999). Epithelial cell architecture must exhibit polarity for them to 
meet these functional demands. Intestinal epithelial cells (IECs) are in charge of two crucial 
processes: transporting nutrients and fluids and the restricting the access for luminal antigens 
to the internal milieu (Madara et al., 1987). These cells express intercellular connections 
known as tight junctions (TJs), which form a largely impermeable barrier to prevent unspecific 
penetration of molecules and microorganisms into the body, and possess different types of 
transmembrane proteins such as occludin, claudins and junctional adhesion molecule (JAM) 
for regulating TJ assembly and function (Fanning et al., 1999). These molecules extend into 
the intercellular space and determine the permeability characteristics of TJs in terms of 
specificity and tightness (Harhaj & Antonetti, 2004). Barrier disruption is an important 
etiologic factor of intestinal inflammation, causing not only defective nutrient uptake and 
retention, but also increased permeability to luminal antigens with subsequent contact and 
activation of underlying immune cells (Harhaj & Antonetti, 2004).  
 Metabolism of DON is used to describe conversion of the native toxin to various 
degradation derivatives occurring mainly in the digestive tract with high concentrations. 
Substantially lower levels were detected in organs such as kidney, liver, heart, lung, spleen 
and brain. Derivatives of DON include its microbial metabolised de-epoxidized form, called 
de-epoxy-DON, DOM-1 (DON metabolite 1) or simply de-DON (Figure 3), and their 
conjugated forms as a result of the phase I and II metabolism (Danicke & Brezina, 2013). The 
only metabolite in pigs, DOM-1 or de-epoxy-DON, was identified by gas chromatography–
mass spectrometry (GC-MS). Several microorganisms in the caudal segments of the gut, 
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particularly the colon content, showed the strongest metabolic activity for reduction of 12-13 
epoxide group of DON which is responsible for its toxicity. Also, DON and DOM-1 were 
present in the kidneys and were found to be higher in muscles and liver (Doll et al., 2008). 
The first effect is mediated by different gastrointestinal and hepatic enzymes that result 
in the oxidation, reduction or hydrolysis (phase I reactions). Phase I, also called transformation 
phase, includes reactive groups which are introduced into the molecules by oxidation or 
dealkylation for instance. In many cases, activation of the molecules through phase I 
biotransformation is necessary for conjugation, but if the reactive groups are already present in 
the parent molecule, they may undergo direct conjugation (Berthiller et al., 2007). 
 Phase II includes sulfation and glucuronidation reactions, along with glutathione 
conjugation, methylation, amino acid conjugation, and acetylation of DON considered as 
detoxification pathways, which increase the water solubility. Phase II detoxification typically 
involves biochemical conjugation by which various enzymes in the liver attach small chemical 
moieties of the toxin. Phase II enzymes are also widespread in extra-hepatic tissues, especially 
in the lungs, kidneys, skin and gastrointestinal tract (Goyarts & Danicke, 2006). 
Glucuronidation is a significant pathway in the detoxification mechanism of Phase II. 
Glucuronidation requires the enzyme UDP glucuronyltransferase to combine glucuronic acid 
with the toxin. The degree of conjugation varies markedly and depends on tissue-specific 
activities of the UDP-glucuronosyltransferases and sulfotransferases (Goyarts & Danicke, 
2006).   
Following oral intoxication of DON, 68% of the toxin is excreted in the urine as DON, 
DOM-1 and glucuronide-DON. The remaining DON (20%) is eliminated in faeces as DON, 
DOM-1 and low amounts of 3-ADON. Excretion mechanisms of DON/DOM-1 and 
glucuronide-DON/DOM-1 are unknown; however, they could involve both glomerular 
filtration of the metabolites present in the blood and their excretion though P-glycoproteins 
expressed by intestinal, renal or hepatic epithelial cells (Goyarts & Danicke, 2006; Eriksen et 
al., 2003). IV and intragastric administration of high concentrations of DON (3000-1000ppb) 
suggested that DON was very rapidly absorbed and eliminated. However, residues remain in 
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pigs because of the extensive systemic distribution and the poor metabolism of DON by 
different organs (Prelusky et al., 1988). 
 
 
 
 
 
 
 
 
 
 
Figure 3: Metabolism of DON in pig. Modified from Danicke and Brezina (2013). 
1.4 Toxicological effects 
1.4.1 Acute toxicity  
 The common toxicity symptoms following acute DON poisoning in sensitive species 
such as pigs include abdominal distress, increased salivation, discomfort, anorexia, diarrhea 
and emesis. Also, a complete feed refusal is evident at 12 mg/kg (Rotter et al., 1994). 
Although DON is less toxic than T-2 toxin, extremely high DON concentrations (≥27 mg/kg) 
can cause shock and death in pigs (Pestka, 2007). Lethal DON concentrations (≥ 27 to 30 
mg/kg) evoke histopathologic effects ranging from hemorrhage/necrosis of intestinal tract, 
necrosis of bone marrow and lymphoid tissues as well as kidney and heart lesions (Forsyth et 
al., 1977; Pestka et al., 1987). 
1.4.2 Chronic toxicity  
 Prolonged dietary exposure to DON causes decreased weight gain, anorexia, and 
altered nutritional efficiency. It was suggested that monogastric species such as mice and pigs, 
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experience severe growth and weight gain suppression during chronic exposure to DON 
(Pestka, 2007). Deoxynivalenol concentrations at 1-2 mg/kg caused partial feed refusal in pigs 
ingesting naturally contaminated feed (Pestka et al., 1987). However, pigs fed with DON 
concentrations at 2 mg/kg showed loss of weight gain during the first 8 weeks and DON 
concentrations at 4 mg/kg decreased feed intake, weight gain and efficiency of feed utilization 
(Bergsjo et al., 1992). In conclusion, pigs are very sensitive to growth performance and weight 
suppression following a DON diet contamination exceeding 1 mg/kg.  
 
1.5 Protein synthesis inhibition  
 
Deoxynivalenol binds to ribosomes (40S and 60S) in eukaryotic cells and produces 
protein synthesis inhibition (Ueno, 1984). Most of the trichothecenes predominantly inhibit 
initiation and DON is an inhibitor of elongation of protein synthesis which requires the 
presence of unsaturated bond at the C9-C10 position, integrity of the 12, 13 epoxy ring, 
substitution of the hydroxyl of other groups at appropriate positions on the trichothecene 
nucleus, and the structure and position of a side chain. (Dänicke et al., 2000; Ueno, 1984). 
Therefore, these features can all influence the extent of cytotoxicity and protein synthesis 
inhibition. The opening of the 12-13- epoxide ring results in loss of any apparent toxicity. The 
effect of a particular trichothecene on protein synthesis depends on the number and position of 
the hydroxyl groups and on the type of esterifying acids (Betina, 1989). Deoxynivalenol with 
substituents at both C-3 and C-4 predominantly inhibit polypeptide chain initiation. The 
cytotoxicity of DON, a trichothecene with a keto group at C-8 and a hydroxyl group at C-7, 
results from protein synthesis inhibition at the ribosomal level during the elongation and 
termination step in mammalian cells (Ueno, 1983; Ehrlich & Daigle, 1987). 
As we know, the most prominent molecular target of DON is the mentioned 60S 
ribosomal subunit. Deoxynivalenol enters cells and binds to active ribosomes, which transduce 
a signal to protein kinase R (PKR) and hemoitopoeitic cell kinase (Hck) by different 
mechanisms involved in this inhibition of translation. First, in phagocytes, DON can induce 
activation of ribosome-associated kinase known as double-strand RNA associated PKR. When 
activated, PKR can phosphorylate eukaryotic initiation factor 2α (eIF2α) impeding translation 
(Zhou et al., 2003). Second, DON can promote intracellular 28S rRNA cleavage, potentially 
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by facilitating the action of endogenous RNases or by upregulating RNase expression, which 
could impede ribosome function and translation (Li & Pestka, 2008). A fundamental issue 
relates to the nature of the linkage between ribosomal RNA damage and induction of MAPKs 
(Mitogen-activated protein kinase) signaling cascades. Unidentified intermediate signal 
transduction steps, possibly protein-mediated, might occur between toxicant-damaged 28S 
rRNA and MAPKs (Iordanov et al., 1997). Third, DON can up-regulate a large number of 
micro RNAs (miRNAs), with selected gene downregulation. Thus, it might be speculated that 
DON-exposed cells employ miRNA downregulation of ribosome synthesis to conserve and 
redistribute resources needed for survival (Pestka, 2010). It is also known that DON and other 
translation inhibitors which bind to ribosomes can rapidly transduce a signal to PKR and Hck 
to activate MAPKs and induce apoptosis, a process known as the “ribotoxic stress response”. 
MAPKs module physiological processes including cell growth, differentiation and apoptosis 
which are critical to the signal transduction of immune response (Figure 4) (Zhou et al., 2005).  
            Mitogen-activated protein kinase subfamilies include p44 and p42 also known as 
extracellular signal-regulated protein kinase 1 and 2 (ERK1 and 2), p54 and p46 c-Jun N-
terminal kinase 1 and 2 (JNK 1/2) and p38 MAPK. MAPKs are activated by dual 
phosphorylation at the tripeptide motif Thr-Xaa-Tyr (Dong et al., 2002). The sequence of this 
tripeptide motif is different in each group of MAPKs: ERK (Thr-Glu-Tyr); p38 (Thr-Gly-Tyr); 
and JNK (Thr-Pro-Tyr). The dual phosphorylation of Thr and Tyr is mediated by a conserved 
protein kinase cascade. The ERK MAPKs are activated by the MAP kinase kinases (MKK) 
MKK1 and MKK2; the p38 MAPKs are activated by MKK3, MKK4 and MKK6; and the JNK 
pathway is activated by MKK4 and MKK7 (Casteel et al., 2010; Pestka, 2008; Zhou et al., 
2005). 
 In macrophages, ERK and p38 are involved in DON induced transactivation of TNF-α 
and cyclooxygenase-2 (COX 2), whereas p38 appears to be involved in DON mediated mRNA 
stability (Moon & Pestka, 2003). This activity is possibly restricted to selected stages of the 
ribosomal cycle. These two kinases (PKR and Hck) potentially mediate signalling of DON to 
induced MAPK activation resulting in ribotoxic stress response (Zhou et al., 2003; Iordanov, 
1997). 
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 Protein kinase R is a member of a small family of kinases, which are expressed 
seritine/threonine protein kinases activated by extracellular stress and phosphorylate the α-
subunit of protein synthesis eukaryotic initiation factor 2 (eIF-2), thereby inhibiting protein 
synthesis. The activation of PKR during infection by viral double strand RNA (dsRNA) 
intermediates results in the inhibition of viral replication. Protein Kinase R also mediates the 
activation of signal transduction pathways by pro-inflammatory stimuli, including 
lipopolysaccharide (LPS), TNF-α, and interleukin (IL)-1 (Williams, 2001). Moreover, it is 
known that PKR is a critical upstream mediator of the ribotoxic stress response induced by 
DON resulting in a critical upstream role in the ribotoxic stress response inducible by 
translational inhibitors (Zhou et al., 2003). 
One distinct family of protein tyrosine kinases consists of Src non-receptor tyrosine 
kinases (NRTKs) which have been called “rheostats for immune signalling”. One member of 
this family is Hck which transduces a variety of extracellular signals capable of impacting 
cellular processes related to proliferation, differentiation and migration. The Src family of 
protein kinases (SFKs) can be divided into two groups: those that exhibit a relatively 
ubiquitous pattern of expression (Src, Yes, Fyn) and those whose expression is restricted to the 
hematopoietic system, such as Lck in T lymphocytes and Hck in myelomonocytic cell lineages 
(Ernst et al., 2002; Moarefi et al., 1997). The Src-family-selective tyrosine kinase inhibitors 
PP1 and PP2 effectively block DON to activate MAPKs, which suggest involvement of the 
Hck. The PP1 reduces DON-induced increases in nuclear levels and binding activities of 
several transcription factors (NF-κB, AP-1, and C/EBP), which corresponded to decreases in 
TNF-α production, caspase-3 activation, and apoptosis. As expected for a signalling event 
upstream of MAPK activation, tyrosine phosphorylation of the Hck was detectable as early as 
1 min, maximized at 2.5 min then declined within 30 min after DON addition (Zhou et al., 
2005; Ernst et al., 2002). 
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Figure 4: Molecular mechanism of action of deoxynivalenol and other trichothecenes. 
Reproduced from Pestka et al., (2007). 
1.6 Cytotoxicity 
 Numerous studies of DON’s cytotoxicity have been conducted because of DON’s 
capacities to alter host resistance, humoral and cell-mediated responses, cytokine expression, 
and apoptosis of lymphoid tissue in humans and animals (Sobrova et al., 2010). The common 
theme is that DON can be immunostimulatory or immunosuppressive depending on the dose 
and exposure frequency (Bondy & Pestka, 2000). Immunosuppression can be explained by the 
inhibition of translation when DON binds to the active ribosomes and immunostimulation can 
be related to interference with normal regulatory mechanisms (Bondy & Pestka, 2000; Rotter 
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et al., 1996). Stimulation of macrophages by DON at the concentration of 1 to 2 mg/kg could 
upregulate the expression of inflammation-related genes in vivo and in vitro. These include 
COX-2 and pro-inflammatory cytokines (Zhou et al., 2005; Moon & Pestka, 2002).  Exposure 
to DON concentrations at 3 to 5 mg/kg upregulates the expression of many immune-related 
proteins, including Th1 and Th2 cytokines as well as chemokines. In contrast, it appears that 
the suppressive effects of DON on leukocyte function are intimately linked to the induction of 
apoptosis of macrophages, T cells and B cells isolated from peyer’s patches (PP), thymus, and 
bone marrow, which represent the functional cell repertoire of the immune system. Thus, 
DON immune modulation might be considered as a spectrum whereby low doses stimulate 
immune function, while high doses increase leukocyte apoptosis leading to 
immunosuppression (Pestka et al., 2004; Pestka et al., 1994). 
1.7 Gene upregulation 
  Selective elevation of cytokines, chemokines and other immune-related proteins by 
DON is immediately preceded by increased expression of their mRNAs. For example, DON 
upregulates mRNAs of TNF-α by increasing transcription and mRNA stability through 
activation of p38 and interleukin (IL)-6 in macrophages (Chung et al., 2003).  
Mice fed with a diet containing DON concentrations at 10 mg/kg dysregulates 
immunoglobulin (Ig) A production in serum and results in immunopathology. The mechanism 
by which DON induces IgA dysregulation is unclear. However, the gut mucosal compartment 
may be a primary target of DON to produce the aberrant stimulation of the gut mucosal 
immune system (Jia & Pestka, 2005). Deoxynivalenol can induce proinflammatory cytokines, 
particularly IL-6 which could impair oral tolerance and with subsequent polyclonal activation 
of IgA-committed B cells to terminal differential (Pestka & Zhou, 2000). This appears to 
contribute to high concentrations of serum IgA as well as IgA deposition in the kidney and 
DON could be an etiological factor in IgA nephropathy (IgAN).  
 
The capacity of DON to expand polyclonal IgA-secreting cells in mice is mediated by 
increased cytokine, mainly IL-6 production by macrophages and T cells. These lymphocytes 
can be involved in the polyclonal expansion of IgA secreting cells which is observed in mice 
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fed with DON (Pestka, 2003; Pestka et al., 1989). A study provided evidence that dietary 
DON enhanced terminal differentiation of IgA secreting cells in PP. The migration of IgA 
secreting cells into the systemic compartment favours a shift from IgG to IgA as the primary 
serum isotype. At the same time, there is an increased help for terminal differentiation of 
control PP B cells upon addition of T cells from PP of DON-fed mice (Pestka, 2003).  
On the other hand, DON-mediated elevations in cytokines, chemokines, immune 
related proteins and enzymes induce of COX-2. Selective inhibitor COX-2 is an enzyme that 
catalyzes oxygenation of arachidonic acid to transform prostaglandin H2 (PGH2) 
endoperoxides which are subsequently converted to prostaglandins and thromboxane A2. Also 
COX-2 stimulates cancer cell proliferation and promotes angiogenesis (Moon & Pestka, 2002; 
Tsuji et al., 2001; Smith et al., 2000). Selective inhibitor COX-2 induced production of 
prostanoids that are often involved in inflammatory diseases, characterized by edema and 
tissue injury due to the release of many inflammatory cytokines and chemotactic factors, 
prostanoids, leukotrienes, and phospholipase (Arslan & Zingg, 1996).  
1.8 Other animals affected by DON 
1.8.1 Cows 
The impact of DON on dairy cattle is not established and the susceptibility of 
ruminants to DON is low, as DON is converted almost completely into a less toxic metabolite, 
DOM-1 by the rumen flora (Fink-Gremmels, 2008). No effects were detectable in rumen and 
duodenal flow in dairy cows even if they were fed DON at 7 mg/kg. The toxin was nearly 
completely metabolized to DOM-1 indicating a complete degradation (Danicke  et al., 2005). 
However, other clinical data showed an association between DON and poor performance in 
dairy herds. Cows fed DON at 2.6 to 6.5 mg/kg produced less milk (13% or 1.4 kg) compared 
to cows on uncontaminated feed (Charmley et al., 1993).  
1.8.2 Poultry 
In general, poultry have a tolerant nature to the presence of dietary DON with feeds 
containing low concentrations at 1 to 5 mg/kg. Reasons for poultry tolerance to DON probably 
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include poor toxin bioavailability and rapid elimination from the body (Danicke et al., 2001). 
It has been suggested that dietary DON concentration at 5 mg/kg was necessary to negatively 
influence the growth performance of broilers. It was also demonstrated that DON has the 
capacity to decrease absorption of nutrients such as glucose and amino acid in the small 
intestine and to impair immune functions in broilers by inducing changes in the 
haematopoietic system and by altering lymphocytes’ proliferation (Awad et al., 2008). 
1.8.3 Rats/mice  
Absorption and clearance of DON in rodents is also rapid: mice and rats are sensitive 
to DON but there seems to be differences in the kinetic, metabolism and tissue distribution of 
DON. Studies have demonstrated that DON reduces weight gain. For example, female mice 
B6C3F1 were fed with a high fat diet for 8 weeks to induce obesity. Then mice were fed DON 
concentrations at 0, 2, 5, 10 mg/kg for an additional 8 weeks. Animal fed with higher DON 
concentrations, i.e. 5 and 10 mg/kg, showed a decrease of 16 and 23% in weight gain 
respectively (Flannery et al., 2010). 
1.9 Control measures to reduce DON contamination  
 The proliferation of Fusarium in cereal crops may occur when the development of 
mycelia is followed by ascospores’ production in sexual fruiting structures located on the 
surface of the pathogen-infested residue. The incidence is most closely related to the presence 
of moisture at the time of flowering and during and after rainfall, rather than to the amount of 
rain or the distribution of [14C] DON on crop debris (Miller, 1994).  
Consequently, measures taken to control or minimize Fusarium infection will also 
reduce DON formation. Such measures include agronomic practices, cultivars, use of 
fungicides, biocontrol and genetic resistance, which are the most dependable and cost-
effective ways to control Fusarium head blight (FSB). Agronomic practices include suitable 
crop rotation, appropriate use of fertilizers, irrigation, and weed control (Milus & Parsons, 
1994) Maize-wheat rotation increases the incidence of FHB and should be avoided, whereas 
removal or ploughing of crop debris reduces the incidence in wheat. Rotation with non-
graminaceous crops such as soybean, burial or burning of corn residue appears to be very 
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effective approaches for removing the substrate of Fusarium proliferation (Bai & Shaner, 
1994).  
 High concentrations of nitrogen fertilizer may increase plant water stress. Effective 
weed control may be useful in reducing Fusarium inoculum, but the efficacy of weed control 
in reducing FHB is debated. Irrigation may avoid water stress and reduce the severity of 
Fusarium foot rot in wheat, which may serve as an inoculum for the development of FHB 
(Milus & Parsons, 1994). Experimental work in plots revealed significant differences in the 
activity of fungicides against the FHB pathogens. Those that effectively controlled the 
mycotoxin-producing pathogens also decreased the concentrations of DON in grain (Milus & 
Parsons, 1994).  
 Biocontrol measures exist to inhibit DON production by the pathogen and directly 
reducing DON concentration in grains. One of these strategies is to use endophytic 
microorganisms which inhabit plant tissues without causing disease or other effects, as an 
antagonist against the pathogen (Schardl et al., 2004). Endophytic fungi and bacteria have 
been found in graminaceous plants producing ecological benefits to the grass host. The ability 
for these fungi to be active within plant tissues such as seed and to be vertically transmitted, 
confers a distinct advantage to this group over the conventional biocontrol agents (Schardl et 
al., 2004).  
Another strategy to inhibit Fusarium is to apply isolated microorganisms to prevent 
saprophytic growth and perithecial development by the pathogen. Research in Canada using 
Microshaeropsis sp demonstrated its capacity to decrease perithecia production by G. zeae; 
however, the size of inoculum reductions required for appropriate control of Fusarium is too 
high to consider it alone (Bujold et al., 2001). A study of communities of reduced numbers of 
residue saprophytic fungi including Fusarium spp showed that residue decomposition rates 
had been slowed by 23%. Thus, it appears that while fungicides might directly inhibit the 
growth of the pathogen in residue, they might have a negative effect on colonization by 
competitive, decomposing microbes (Beare et al., 1993). 
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Other methods of reducing toxicity to minimize risk factors which influence the 
contamination of cereals with DON included physical methods such as cleaning, mechanical 
sorting and separation, thermal inactivation, irradiation, ultrasound, and chemical procedures 
such as solvent extraction, treatment with acid/base solutions or ammonization and ozonation 
(Kabak & Dobson 2009). Numerous chemicals have been tested for their ability to 
decontaminate trichothecene-contaminated grain or feed. Sodium bisulfite is a common food 
additive and is used as treatment of grains contaminated with DON. The DON concentration 
was reduced with increasing amounts of sodium bisulfite reacting with DON to form DON–
sulfur adducts, which are unstable at high temperatures and basic pH (Young, 1986).  
Another approach for reducing toxicity in feedstuffs is the use of adsorbent materials. 
Adsorbent materials present in animal feed are compounds that should be able to bind 
mycotoxins during passage through the gastrointestinal tract under all pH, temperature and 
moisture conditions. These materials could reduce absorption and systemic toxicity (Döll & 
Dänicke, 2004). On the other hand, the addition of mycotoxin binders to contaminated diets 
has been considered the most promising dietary approach to reduce effects of mycotoxins. 
Mycotoxin binders have been evaluated using both in vitro and in vivo systems. In vitro 
evaluations are used for potential binder products, providing an idea of binding affinity and 
capacity. In vivo studies have generally used performance responses or biological markers 
such as tissue residues or changes in biochemical parameters to determine effectiveness of 
binders (Whitlow, 2006). Among the mycotoxin binders are the activated carbon which can 
increase binding to mycotoxins such as DON. Complex indigestible carbohydrate polymers 
derived from yeast cell walls are shown effective in binding aflatoxin and restoring 
performance to animals consuming multiple mycotoxins (generally Fusarium produced) 
(Whitlow, 2006).  
 On the other hand, legislation exists to prevent the sale of any feed containing 
toxicological levels or unacceptable amounts of contaminants from an animal and human 
health point of view. Contaminant levels are required to be kept as low as can reasonably be 
achieved by good practice. In most countries, regulations are established to control the 
contaminants in foodstuffs to protect animal health; they may include specific maximum limits 
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for several contaminants in various foods and a reference to the sampling methods and 
performance criteria of analysis to be used (Table 1) (Mycotoxins Legislation Worldwide, 
2014). 
Table 1: Recommended tolerance levels (mg/kg) of several mycotoxins in Canada. 
Reproduced from Center for Veterinary Medicine/Food and Drug Administration Draft report, 
2015. 
Mycotoxin Feedstuff 
Tolerance levels 
(mg/kg) 
T-2 toxin Compound feed for pigs 0.5-1 
Deoxynivalenol 
Complementary and complete 
feedingstuffs for pigs 
0.5-1 
Zearalenone 
Complementary and complete 
feedingstuffs for piglets and 
gilts 
0.1 
Fumonisin B1 + B2 
Complementary and complete 
feedingstuffs for pigs 
5-10 
Ochratoxin A 
Complementary and complete 
feedingstuffs for pigs 
0.05 
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2. Porcine reproductive and respiratory syndrome 
2.1 Generalities 
Porcine reproductive and respiratory syndrome (PRRS) is present worldwide and is the 
most economically important infectious disease of swine production causing significant 
economic losses in the Canadian industry of approximately $130 million per year (Mussell, 
2010). Since its emergence as a clinical entity in the late 1980s, PRRS has proven to be a 
persistent and insidious threat to the health and productivity in North American swine herds 
(Neumann et al., 2005). 
In herds with multiple secondary diseases, co-infection with bacteria and viruses can 
exacerbate PRRS associate diseases. The disease has many clinical manifestations in sows, 
which are mainly late term abortions, increased number of stillborn and mummified or weak 
born pigs. In pigs of all ages, the disease is associated with respiratory problems (Cho & Dee 
2006). 
2.2 Clinical disease  
Host factors such as breed, genetic, and age are important in the virulence and 
epidemiology of PRRSV. However, this also depends upon the genotype of the virus, viral 
entry, tissue persistence, and lesions inducing pneumonia, myocarditis, encephalitis, rhinitis, 
vasculitis, and lymphoid necrosis. Virus pathogenicity studies will help explain variations in 
the severity of the clinical disease observed in PRRSV field outbreaks (Halbur et al., 1996; 
Rossow et al., 1996; Halbur et al., 1995b). 
2.2.1 Clinical signs  
The clinical signs of PRRS vary greatly according to age, the immune system status, 
the virulence of the strain and the host defense against secondary infections (Rossow et al., 
1999). Infection with PRRS shows two different sets of clinical signs, reproductive and/or 
respiratory (Keffaber, 1989). In general, porcine reproductive and respiratory syndrome virus 
(PRRSV) inoculated pigs had a slower onset, lower severity and duration of clinical 
respiratory disease compared to direct contact exposure pigs (Halbur et al., 1996). One of the 
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he most important symptom of PRRSV is emaciation. Pigs become emaciated due to weight 
loss, hyperthermia (39.7°C and 41.1°C), lethargy, anorexia, slowed abdominal respiration and 
tachypnea (Rossow et al., 1994).  Skin symptoms are rare such as a rough hair coat, patchy 
dermal cyanosis, blue-purple discoloration of the skin when stressed by handling and 
chemosis.(Halbur et al., 1996; Halbur et al., 1995b; Rossow et al., 1994). Also, there are 
others typical clinical signs observed in PRRSV such as, late term-abortions and fetal death, 
early farrowing, mummified fetuses, stillborn and weak piglets (Lager et al., 1997b; 
Christianson et al., 1992). 
Virulent PRRSV strains are able to induce elevated levels of viremia, affecting weight 
gain, death-rates and cause severe respiratory signs with persistent lung lesions (necrotizing 
interstitial pneumonia) (Johnson et al., 2004). Young pigs exposed to PRRSV are more 
susceptible to infection than mature pigs and show higher virus excretion (Halbur et al., 
1995b). In general, PRRSV type 2 strains induce higher severe respiratory disease compared 
to PRRSV type 1 strains. (Van der linden et al., 2003; Halbur et al., 1995a). 
2.3 Etiology 
The disease was first described in North Carolina, Iowa and Minnesota in 1989 
(Keffaber et al., 1989). It was reported as catastrophic clinical outbreaks of an unrecognized 
disease (Hill, 1990). The etiological agent of PRRS was identified for first time in Europe and 
it was named Lelystad virus because it was first isolated at the Central Veterinary Institute in 
Lelystad, the Netherlands and it could only be isolated and grown in porcine alveolar 
macrophages but not in the other cell line tested (Wensvoort et al., 1991).  
PRRS virus (PRRSV) is an enveloped, single-stranded-positive sense, RNA virus of 
approximately 50-65 nm in diameter and is classified in the order Nidovirales, family 
Arteriviridae, genus Arterivirus along with equine arteritis virus, lactate dehydrogenase-
elevating virus of mice and simian hemorrhagic fever virus (Benfield et al., 1992). 
2.3.1 Virus morphology 
The virion is mostly spherical in shape, enveloped, and possesses a non-segmented 
single strand RNA genome that is encapsidated by the nucleocapsid protein (N) (Dea et al., 
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2000). The PRRSV capsid has a helical structure of 20-30 nm in diameter, which is 
surrounded by a lipid envelope containing viral envelope proteins (Spilman et al., 2009; 
Benfield et al., 1992). Some studies have demonstrated that RNA forms the centre of N 
proteins while others have proposed that the RNA is wound around the outside of N protein 
core (Spilman et al., 2009).  
2.3.2 Virus characteristics 
The PRRS virion is heat labile but relatively stable for long periods of storage at -70 
o
C 
and -20 
o
C. The thermolability of this virus was established at higher temperatures and the 
half-life was 140 h at 4 
o
C, 20 h at 21 
o
C, 3 h at 37 
o
C and 6 min at 56 
o
C (Bloemraad et al., 
1994). 
Refrigeration is sufficient for preservation of specimens for virus isolation for shorts 
periods; otherwise the virus samples can be frozen for several months or longer (Benfield et 
al., 1992). It is important to note the ability of the virus to infect animals through the aerosol 
route as the half-life of infectious virions in aerosols at a temperature of 7.1 °C and a relative 
humidity of 89% would be approximately 74 min. However, the infectivity of the virion in 
aerosols increased with a higher wind velocity and potentially lower sunlight intensity (Dee et 
al., 2009). 
2.3.3 Genotypes 
Porcine reproductive and respiratory syndrome virus is classified into two distinct 
genotypes: formerly European and now officially type I is represented by Lelystad virus (LV) 
and formerly North American and now officially type 2 represented by ATCC VR-2332. 
These two genotypes share approximately 60% of genome sequence homology (Hanada et al., 
2005) 
The type 1 and 2 strains of PRRSV can also be differentiated from each other based on 
common and type specific antigenic determinants present on the structural proteins. Some 
regions are similar as the ORF1b product and some structural proteins are more conserved 
between ATCCVR-2332 and LV. As an example, the open reading frame 1b (ORF1b) is more 
conserved than ORF1a (Nelsen et al., 1999). 
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2.3.4 Genome organization  
The PRRS virion contains a RNA genome of approximately 15.4 kb in length with a 
5’-end methylated cap structure and a polyadenylate 3’-end. Open reading frame 1a and 
ORF1b constitute about 75 % of the genome, and encode two long non-structural 
polyproteins, pp1a and pp1ab in 5′-terminal 12-kb region. The structural proteins are 
expressed from the 3′-terminal 3-kb region sharing the common leader sequence at the 5’ 
terminus and encodes at least ten open reading frames (ORFs) (Wei et al., 2012; Fang & 
Snijder, 2010; Snijder, 1998a; Snijder et al., 1994). In the 3′- terminal quarter of the genome 
ORF 2-5 encodes the membrane glycoproteins GP2-GP5. ORF6 and 7 encode a non-
glycosylated membrane protein (M) and the nucleocapsid (N) protein, respectively (Figure 5). 
Two small genes, ORF2b and ORF5a, are fully embedded in ORF2 and depending on the 
genotype partially or fully embedded in ORF5, encodes the non-glycosylated proteins E and 
ORF5a protein (Johnson et al., 2011; Firth et al., 2011). Non-structural proteins (nsps), nsp1, 
nsp1β, nsp2-6, nsp7α, nsp7β and nsp-8-12 are encoded by ORF1a and ORF1b. The nsps are 
involved in processing of the viral polyproteins, genome replication and transcription (Figure 
5) (Kroese et al., 2008; Meulenberg, 2000). 
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Figure 5: Schematic representation of PRRSV genome organization.  (A) The ORFs are 
shown as solid rectangles from 5’ to 3’ end with the appropriate ORF named on it. The 
replicase ORFs (ORF1a and ORF1b) are followed by ORF encoding 2b protein and three 
ORFs encoding three minor envelope glycoproteins (GP2a, GP3, and GP4), and ORFs 
encoding major structural proteins (GP5, M, and N). (B) Overview of the ORFs encoding nsps 
of PRRSV. ORF1a and ORF1b are labelled and nsps encoded by each of the ORFs are shown. 
The protein ORF5a is not illustrated. Reproduced from (Beura, 2011). 
2.3.5 The non-structural proteins 
Open reading frame 1a (ORF1a) and ORF1b encode at least 12 nsps above identified 
and together span approximately 75% of the genome from the 5’-end (Li et al., 2012). The 
pp1a and pp1ab are processed into the 12nsps by a complex proteolytic cascade that is 
directed by four proteinase domains encoded in ORF1a (Figure 6) (Fang & Snijder, 2010, 
Ziebuhr et al., 2000). 
The nsp1α is the viral component responsible for modulation of type I IFN response 
and is important for subgenomic mRNA synthesis (Li et al., 2012; Kim et al., 2010; 
Meulenberg, 2000). Whereas, the nsp2α is required for genome replication and forms a non-
covalent interaction with nsp3 which support the formation of vesicles and the double 
membrane of the replication complex (Beura, 2011). The replication cycle of PRRSV depends 
on cleavage products of nsp1α and nsp1β that occurs between Met and Ala amino acids (aa) of 
putative cleavage sites Cys-Ala-Met180-Ala-Asp-Val and the carboxy terminal PCP domain 
are required for this cleavage (Kroese et al., 2008). Also, the function of nsp2 is as cofactor in 
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the protease activity of nsp4 for cleavage of the polyprotein-1a and polyprotein-1b (Snijder et 
al., 1994). 
Protein products nsp5-8 are not well described and have currently unknown functional 
structure (Dokland, 2010). The nsp9 (RNA dependent RNA polymerase, RdRp), nsp10 
(helicase), nsp11 (a Xenopus laevis homolog poly [U] specific endoribinuclease known as 
nidoviral endonuclease specific for U [NendoU]), and nsp12 are encoded by ORF1b of 
PRRSV (Li et al., 2012).  
 
Figure 6: Schematic representation of the PRRSV non-structural proteins. The replicase 1a 
and 1ab polyproteins (ppla and pp1ab) are expressed from the genomic viral RNA. The 
structural proteins are expressed from a nested set of sg mRNAs, RNAs 2–7. The pp1a is 
predicted to be cleaved at eight sites to form nine nsps: nsp1a, nsp1b and nsp2 to nsp8. The 
processing of pp1a and pp1ab is mediated by accessory proteinases located in nsp1 (papain-
like cysteine proteinases: PCPα and PCPβ). Reproduced from (Music & Gagnon, 2010). 
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2.3.6 Structural proteins 
2.3.6.1 Minor structural proteins 
Three minor glycoproteins (GPs) GP2a, GP3, and GP4 of PRRSV are present into the 
viral envelope and are translated from ORF2a, 3, 4 into 256 aa, 254 aa, and 178 aa long, 
respectively (Figure 7). The glycosylated forms of these proteins have predicted sizes of 
approximately 29 kDa, 29 kDa and 20 kDa, respectively (Das et al., 2010).  
The GP2a protein has two N-glycosylation sites and also interacts with PRRSV 
receptor CD163 (Das et al., 2010). This protein is assembled into virion as a heteromultimeric 
complex together with the GP3, GP4 and GP5 proteins and this complex is required for 
particles to become infectious (Wissink et al., 2004). 
The GP3 protein is a highly antigenic glycosylated envelope protein with seven 
predicted glycosylation sites and secreted a non-structural protein for a type 2 strain, the IAF-
Klop (Gonin et al., 1998). The GP3 is heavily N-glycosylated and contains seven N-
glycosylation motifs (N27,N42, N50, N130, N151, N159, and N 194 for type 1 and N29, N42, 
N50, N131, N152, N160,N196 for type 2) (Dea et al., 2000). 
The GP4 possesses four N-glycosylation sites. The most variable region of GP4 
possesses the neutralizing epitopes and is located between aa 40 and 79 (Meulenberg et al., 
1997; Meulenberg et al., 1995). It appears that the GP4 is a critical viral envelope protein that 
not only mediates interactions with other GPs on the virion envelope, but also along with 
GP2a, mediates interactions with the CD163 for virus entry (Das, 2010). 
There is a minor non-glycosated protein located within the viral membrane. The small 
E protein is a minor structural protein essential for viral infection (Snijder et al., 2013). The E 
protein is synthesized from the same sg mRNA (mRNA2) as GP2 and is 70 and 73 aa long for 
type 1 and type 2 PRRSV, respectively (Wu et al., 2001). The protein is unglycosylated and 
has a central hydrophobic domain and a hydrophilic C-terminus (Snijder et al., 1999). The E 
protein likely functions as an ion-channel protein and allows ions to enter the virion and 
hereby triggering internal capsid disassembly and promote the release of the viral genome into 
the cytosol (Lee & Yoo, 2006). 
 
 
35 
 
2.3.6.2 Major structural proteins 
The major structural proteins of PRRS virion possess a molecular weight of 15, 18 and 
25 kDa and are designated N, M and GP5, respectively (Figure 7) (Meulenberg et al., 1995). 
The N protein is the most abundant viral protein in infected cells and constitutes 40% of the 
total mass of the virion. It is encoded by ORF7, is non-glycosylated and is the nucleocapsid 
protein pre-dominantly presented as a disulfide-linked homodimer (Dea et al., 2000; 
Meulenberg et al., 1995a ). The N protein of both type 1 and 2 strains of PRRSV has a 
common antigenic region between aa 52 and 69 (Meulenberg et al., 1998 ). 
GP5 is the most abundant glycoprotein found on the surface of the virion. The GP5 is 
found in virions to form heterodimeric complexes with the M protein (GP5–M) and this 
complex is essential for virion assembly and virus infectivity (Meulenberg et al., 1995c; 
Meulenberg et al., 1994). This GP5-M hetero dimer might thus initiate PRRSV infection in 
porcine alveolar macrophages (PAMs) by attachment to a low-affinity receptor, followed by 
interaction of other PRRSV GPs with a high-affinity receptor that determines tropism 
(Wissink et al., 2005; Dea et al., 2000).  
The M protein is a non-glycosylated enveloped protein that is the most conserved 
structural proteins (Kimman et al., 2009). It has a molecular weight of 18 to 19 kDa (Dea et 
al., 2000). The M protein is encoded by ORF6 and has a role in virion assembly (Mardassi et 
al., 1996).  
On the other hand, the conserved proteins in the type I and type 2 strains were 
identified. The GP5 protein is the least conserved structural protein between both genotypes 
(51% to 55% aa identity), whereas the M protein is the most conserved structural protein (75% 
to 81%) (Meulenberg, 2000; Meulenberg et al., 1998). 
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Figure 7: Schematic representation of the PRRS virion and the structural proteins. The 
locations of the structural proteins: GP2a, E (encoded by ORF2) GP3, GP4, GP5, M and N 
(encoded by ORFs 3-7) are shown. The N protein is the sole component of the viral capsid and 
interacts with itself through covalent and non-covalent interactions (homodimer). The major 
envelope viral glycoprotein GP5 forms a heterodimer with the M non-glycosylated protein, 
which dominates the virion external surface. The minor structural proteins (GP2a, E, GP3 and 
GP4) are incorporated into virions as a multimeric complex. The minor structural viral 
proteins multimeric complex also interacts with the GP5-M heterodimer. Taken from (Music 
& Gagnon, 2010). 
2.4 Cell tropism of PRRSV 
The cell tropism of PRRSV is very restricted in vivo and in vitro. In vivo, PRRSV 
replicates within macrophages in the respiratory and lymphoid systems of the pig (Halbur et 
al., 1995a, Halbur et al., 1995b). In pigs the primary target cells for PRRSV replication are 
PAMs (Delputte et al., 2004: Delputte et al., 2007). The virus replicates only in a restricted 
subset of macrophages including the macrophages in the tonsils, lymph nodes, thymus, spleen, 
Peyer
,
s patches, liver, kidneys and lungs within 48 hours of infection (Gomez-Laguna et al., 
2012; Halbur et al., 1996; Halbur et al., 1995b; Rossow et al., 1994).  More than 80% PRRSV 
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infected cells in lungs and lymph tissues were identified as macrophages (Duan et al., 1997). 
However, blood monocytes seem to allow PRRSV replication (Voicu et al., 1994). 
Porcine reproductive and respiratory syndrome virus has been found to infect and 
replicate to high levels in subclones of monkey kidney cell line (MA104) (Benfield et al., 
1992), i.e. MARC-145 cells (Kim et al., 1993) and CL2621 cells (Benfield et al., 1992) which 
are permissive to PRRSV. Recently, Provost et al., (2012) showed that immortalized cell line 
of the respiratory tract of swine St. Jude porcine lung cells (SPJL) was permissive to PRRSV 
infection and replication. Later, these cells were found to be of monkey origin because of their 
chromosomes similarity. SJPL cells are phenotypically similar to MARC-145 cells based on 
cytopathic effect (CPE) development and efficiency to replicate PRRSV. This suggests that 
SPJL could replace the MARC-145 cells for PRRSV replication. 
2.5 Entry and replication of PRRSV 
During in vivo transmission, initial binding of PRRSV occurs to specific receptors. The 
virus is internalized via clathrin-mediated endocytosis. After PRRSV enters through nasal 
epithelium and bronchiolar epithelium, it infects mostly pulmonary macrophages and releases 
its genome (Figure 8). The virus also infects other macrophage lineage such as, pulmonary 
intravascular macrophages (PIM), intravascular macrophages of placenta and umbilical cord 
(Duan et al., 1997).  
Replication of the viral genome occurs in the cytoplasm of the infected cell. The 
proteins involved in replication are encoded in the two major ORFs: ORF1a and ORFb. Open 
reading frame 1a is translated directly from the genomic RNA to the polyprotein 1a (pp1a) 
where ORF1b is translated through -1 ribosomal frameshift (-1PRF) just upstream of the 
ORF1a termination codon resulting in the synthesis of polyprotein 1ab (pp1ab) from ORF1ab 
(Snijder & Meulenberg, 1998). 
The replication of the genomic RNA (mRNA1) starts with the synthesis of full-length 
minus-strand RNA by the binding of the RNA-dependent RNA polymerase (RdRp) enzyme 
complex to RNA signals at the genomic 3’ end. Specific cis-signals present on the 3’ end of 
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both the genomic and the anti-genomic RNA are required for replication (Music & Gagnon, 
2010). 
2.6 PRRSV receptors 
2.6.1 Heparin sulphate 
The virion of PRRS contains several structural proteins that might be involved in the 
attachment to receptors. The first contact between PRRSV and its cell target is taking place 
with the heparin sulphate cell receptor (Delputte et al., 2002). It is assumed that the heparin 
sulfate molecules present on the surface of macrophage act as PRRSV attachment factors that 
help in concentration of virion on the cell surface (Delputte et al., 2005). Also, heparin sulfate 
was reported as the receptor for PRRSV in MARC-145 cells (Jusa et al., 1997). It was shown 
that M protein can interacts with heparin sulphate. The M protein binds with heparin sulphate 
as a disulfide-linked M-GP5 complex (Delputte et al. 2002; Vanderheijden et al., 2001).            
2.6.2 Sialoadhesin  
The Sialoadhesin (Siglec-1) is a macrophage-restricted receptor type I transmembrane 
glycoprotein. It is considered as the attachment and internalization receptor and an entry 
mediator of PRRSV (Van Gorp et al., 2008). The Sialoadhesin is observed in lungs, thymus, 
tonsils, spleen, and lymph nodes in all PRRSV infected cells (Vanderheijden et al., 2003). 
During the entry process into pulmonary macrophages, the virus is attached to the porcine 
Sialoadhesin. Moreover, sialoadhesin could be involved in endocytosis of virus/receptor 
complex by which virions are taken into the cell within vesicles by a clarithin dependent 
pathway. The virus is internalized and a subsequent drop in pH is required, the virus releases 
its genome into the cytoplasm for proper virus replication. (Vanderheijden et al. 2003; 
Nauwynck et al., 1999). 
2.6.3 CD163 
The CD163 receptor is a type 1 transmembrane glycoprotein expressed on cells of the 
monocyte/macrophage lineage closely associated with infection, virus uncoating and genome 
release, localized at cell surface (Sanchez et al., 1999). Additionally, a report has shown that 
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CD163 is also expressed in MARC-145 cells suggesting that it facilitates entry of PRRSV in 
these cells (Calvert et al., 2007). In addition, a contradictory report showed that was not able 
to detect CD163 on MARC-145 cells. However, the expression of CD163 was detected only in 
PAM cells (Provost et al., 2012). Macrophages with high expression of CD163 constitute the 
predominant macrophage population during the late or resolution phase of inflammatory 
reactions caused by PRRSV  (Schaer et al., 2006). 
2.6.4 Cellular proteases 
Aspartic protease cathepsin E and serine proteases are require in macrophages cells 
during PRRSV infection. Those are co-localized with internalized PRRSV and are involved in 
virus uncoating in macrophages cells (Misinzo et al., 2008). Cathepsin E is an intracellular 
aspartic protease homologous to cathepsin D that is localized within the lysosomes of most 
cells (Kageyama,1995), while cathepsin E is localized in various non-lysosomal compartments 
such as the endosome, the endoplasmic reticulum and the Golgi complex and has a limited cell 
and tissue distribution (Rawlings & Barrett, 1995). 
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Figure 8: Model of PRRSV entry into the porcine macrophage. Initially, the PRRSV virion 
attaches to heparin sulphate GAGs present on the macrophage surface (a). Subsequently, the 
virus binds to the sialoadhesin receptor via M/GP5 glycoprotein complexes present in the viral 
envelope (b). Upon attachment to sialoadhesin, the virus–receptor complex is internalized via 
a process of clathrin-mediated endocytosis (c). Upon internalization, the viral genome is 
released from the early endosome into the cytoplasm of the host cell (d), thereby initiating the 
transcriptional and translational events required for the formation of new virions. Scavenger 
receptor CD163 is essential for this genome release and may exert its function through 
interaction with GP2 and GP4. Taken from (Van Breedam et al., 2010a). 
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2.7 Pathogenesis  
 
Transmission of PRRSV primarily occurs through direct contact between the infected 
and naïve pigs (Rossow, 1998). Aerosol transmission is also a route of PRRSV transmission 
(Kristensen et al., 2004), as well as transmission of PRRSV to sows and gilts via semen from 
infected boars (Christopher-Hennings et al., 1995). In the acute p.i. phase, PRRS virus 
replicate in PAM cells and in the nasal and bronchial epithelia. Porcine reproductive and 
respiratory syndrome virus also replicates in pulmonary intravascular macrophages (PIM) 
cells, peripheral blood monocytes, peritoneal macrophages or bone marrow progenitor cells 
(Duan et al., 1997a). This virus can spread from the lungs to the rest of the body, either in the 
blood alone or in association with leukocytes or monocytes which will then migrate to 
different tissues to become tissue macrophages (Prieto & Castro, 2000).  
 This phase is characterized by high viral load in tissue and by the presence of viremia, 
which may last up to 28 days p.i. (Duan et al., 1997; Halbur et al., 1995a, Halbur et al., 
1995b).  The first viremia, after 12 hours p.i., produces a systemic distribution to mononuclear 
cells, tissue macrophages and visceral organs through the lymphatic circulation with the 
subsequent development of interstitial pneumonia, myocarditis, encephalitis, vasculitis and 
lymphoid necrosis (Rossow et al., 1996; Yoon et al., 1992). Through this dissemination, 
PRRSV can reach the reproductive tract, leading to the development of clinical signs 
associated with reproduction, regarding the effects of the virus in early gestation (Prieto & 
Castro, 2000). 
After the virus replication, lungs and alveolar macrophages are the only tissues and 
cells in which PRRSV was persistently detected for 35 days p.i. (Duan et al., 1997). However, 
PRRS virus can be isolated from lymph nodes for more than 100 days p.i. and virus is easily 
transmitted to naïve pigs during asymptomatic periods (Rowland et al., 2003). PRRSV induce 
apoptosis in vivo and in vitro cells (Choi et al., 2002). Subsequently some viral components 
contribute to the apoptosis. Glycoprotein 5 has been reported to be an apoptosis inducer 
(Suarez et al., 1996b). Furthermore, nsp4 induce apoptosis in MARC-145 cells and caspase 3- 
8 and-9 was involved in the induction of apoptosis in PRRSV (Ma et al., 2013). 
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Circulating antibodies against PRRSV are usually detected for the first time at 7 days 
p.i. with a peak between 11 and 21 days p.i. (Halbur et al., 1995b). The largest amount of 
PRRS viral antigen is observed in lung and lymph nodes, but antigens are also observed in 
perivascular and intravascular macrophages in heart, kidney and brain (Gomez-Laguna et al., 
2012; Halbur et al., 1995a), and inconsistently other cells in which viral antigen has been 
detected include pneumocytes, bronchiolar epithelium (Sur et al., 1996), endothelial cells in 
dendritic cells in the lymphoid tissues (Halbur et al., 1995a), spermatocytes, spermatids (Han 
et al, 2013) and muscle tissues (Magar et al., 1995). 
2.8 Pathological lesions  
The lymphoid and respiratory systems show the most severe lesions and are the major 
sites of PRRSV replication. Macroscopic lesions in lungs and lymphoid tissues include mainly 
multifocal interstitial pneumonia and hyperplasia of lymph nodes (Halbur et al., 1995b). 
Macroscopic lesions occur most frequently in the cranial, middle and accessory lobes and the 
ventromedial portion of the caudal lobes. In severe disease, lungs are mottled, tan, and red, 
and fail to collapse; the cranioventral lobes are the most affected (Collins et al., 1992). Other 
lesions include multifocal mild heart lesions usually at perivascular and peri-Purkinje sites. 
Those heart lesions are focal at 7 days p.i. and are characterized by multifocal to diffuse 
lymphoplasmacytic and histiocytic infiltrates more intense in the perivascular peri-Purkinje 
and endocardial regions (Halbur et al., 1995b).  
Moreover, lymph node lesions are primarily in the mediastinal, tracheobronchial, 
mesenteric and medial iliac lymph nodes with mononuclear cell infiltrate and hyperplastic 
lymphoid follicles. Lymph nodes are moderately to severely enlarged and tan in colour and, 
for some virus strains, may be haemorrhagic (Rossow, 1998; Lager & Halbur, 1996). 
Follicular hypertrophy, hyperplasia, and necrosis were also commonly observed in the tonsils 
and spleens (Rossow et al., 1994).  Lesions are also observed in other affected organs such as, 
the inflammation of the stomach and small intestine especially in the ileum, gut-associated 
lymphoid tissues (GALT) lesions in Peyer’s patches hyperplastic and focally necrotic with a 
moderate numbers of necrotic lymphocytes or macrophages (Shang et al., 2013; Halbur et al., 
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1995a). Other lesions are observed in the brain stem, midbrain and white matter of the 
cerebrum (Collins et al. 1992). 
The microscopic lung lesions include interstitial pneumonia that is the most 
characteristic histologic lesion of PRRSV infection. Pulmonary lesions are characterized by 
three main changes: 1) alveolar walls thickened by macrophages, lymphocytes and 
mononuclear cells; 2) type II pneumocytes hypertrophy and hyperplasia; 3) accumulations of 
necrotic debris and macrophages and mixed inflammatory cells in alveolar spaces (Shang et 
al., 2013; Halbur et al., 1995a; Collins et al., 1992; Christianson et al., 1992). In lymph nodes, 
germinal center necrosis, germinal center hyperplasia and hypertrophy, polycystic appearances 
are major lesions observed during PRRSV infection (Rossow et al, 1994). 
In addition, the apoptosis induction is described as a “non-typical”, similar to rubella 
virus and pancreatic virus that culminates in increased cell membrane permeability and formed 
holes in the cytoplasmic membrane during the induction of apoptosis (Kim et al., 2002). The 
intracellular content is released from necrotic infected cells inducing inflammation and 
production of apoptosis in adjacent cells. Apoptosis seems to have a homeostatic effect on the 
number on monocytes/macrophages during the massive influx of the new monocytes in the 
lungs of PRRSV infected pigs (Labarque et al., 2003). 
2.9 PRRSV effect on immune cells  
2.9.1 Role of porcine alveolar macrophages  
Porcine alveolar macrophages (PAMs) are large cells with an irregular shape, variably 
sized nuclei and abundant cytoplasm. PAMs are member of the mononuclear phagocytic 
system, which play an important role in lung defense mechanisms. PAMs are free in the 
alveolar spaces, where they phagocytise inhaled particles (Kouzan et al., 1985). Moreover, 
PAMs are capable of metabolizing arachidonic acid (AA) to its biologically active 
inflammatory metabolites via the lipoxygenase and cyclooxygenase pathways and secrete 
many substances including plasminogen activator, collagenase and vasoactive compounds 
such as prostaglandins, thromboxanes and leukotrienes. The release of these mediators by 
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PAMs is thought to have a central role in regulation of inflammatory reactions occurring in the 
lung (Gomez-Laguna et al., 2012; Bertram et al., 1988).  
Porcine reproductive and respiratory syndrome virus has a high tropism for PAMs. 
These cells are exposed continuously to environmental agents and are less sensitive to 
exogenous triggering signals. The expression of cytokines is weak in PAMs (Gomez-Laguna 
et al., 2010b; Carrasco et al., 2002). After all, PRRSV replicates mainly in PAMs and these 
cells provide one of the first lines of defense against microbial invasion in the lower airways 
(Cheung et al., 2000). Besides their phagocytic and microbiocidal functions, macrophages 
employ many strategies. Among which are antigen processing and presentation to T cells, 
phagocytosis and chemotaxis. Also, they secrete numerous chemical mediators upon 
stimulation, thus playing a role in regulating inflammatory reactions in the lung (Hauschildt & 
Kleine, 1995). 
2.10 Immune response against PRRSV  
2.10.1 Innate immune response against PRRSV 
Host innate immune responses play a key role against early viral infection. Interferons 
are major components of innate immunity and have diverse biological functions including 
antiviral activity, anti-proliferative activity, stimulation of T cell cytotoxic activity, and 
modulation of immune response (Pestka, 2007). Pigs infected with PRRSV fail to generate 
any significant inflammatory cytokine expression in the lungs, including the type I interferons 
(IFN-α/β), interleukin (IL)-1, and tumoral necrosis factor alpha (TNF-α) (Gomez-Laguna et 
al., 2010b; Thanawongnuwech et al., 2001). The expression of type I interferon are crucial 
antiviral cytokines that represent one of the first lines of host defenses for the activation of 
innate immune response (Kimman et al., 2009). The down-regulation of interferon (IFN)-α 
facilities PRRSV replication pathogenesis as IFN-α has been shown to inhibit PRRSV 
replication (Miller et al., 2009). Also, in PRRSV-infected pigs, revealed weak IFN-α titers in 
bronchoalveolar lavage (BAL) fluid. This finding is caused because PRRSV produce minimal 
airway epithelial damage comparing to the classic respiratory virus (coronavirus or swine 
influenza virus) that produce high levels of IFN-α and probably leads to longer survival of the 
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virus in the infected animals (Albina et al., 1998). Nevertheless, this cytokine could not be 
detected in the lungs of PRRSV infected pigs (Van Reeth et al., 1999; Buddaert et al., 1998).  
The expression of IFN- the most potent activating factor for macrophages and 
lymphocytes has been previously reported in the lung of PRRSV-infected pigs to induce 
antiviral mechanisms (Gomez-Laguna et al., 2010b). It was demonstrated that porcine IFN- 
activated macrophages become refractive to PRRSV replication (  et al., 2003). At day 10 p.i. 
IFN- induce an inhibitory effect on PRRSV replication. Therefore, the increase IFN- 
production in the lung may have some negative inflammatory effects on the lung lesions 
(Thanawongnuwech et al.,2003; Bautista & Molitor, 1999). The IFN- production not only 
decreased infectious virus progeny but also reduced the number of cells supporting PRRSV 
replication. In addition, the inhibitory effect of IFN- PRRSV replication appeared to be dose-
dependent (Bautista & Molitor, 1999). 
On the other hand, changes in cytokine expression during PRRSV infection in vivo 
have been described. Infection with PRRSV significantly increased the levels of the majority 
of the cytokines suggesting that inflammation is important for inducing the lung lesions (Liu 
al., 2010). Cytokines, such as IL-1 has shown to induce fever and anorexia (Duff & Durum, 
1983) also, this cytokine play a significant role in the development of interstitial pneumonia 
during PRRSV infection (Gomez-Laguna et al., 2010b). Tumoral necrosis factor-α, is 
generated in large quantities and then is distributed throughout the body (Tracey et al., 1987), 
but PRRSV suppresses the inflammatory cytokine in infected macrophages (Lopez-Fuertes et 
al., 2000). These cytokines are secreted by alveolar macrophages and have various effects on 
the organism that protect the hosts from infection. Despite their effects against pathogens, 
cytokines may also induce inflammation and tissue damage when they are overexpressed (Liu 
et al., 2010). In PAM cells, the expression of IL-1α and IL-6 were generated rapidly in lungs 
after injury but not TNF-α (Thanawongnuwech et al., 2001). However, levels of IL-1, TNF-α 
and specifically IL-10 that may have an important role in the regulation of the immune 
response to PRRSV (Mateu & Diaz, 2008), although IL-1, TNF-α were lower in BAL fluid 
from pigs infected with PRRSV providing a possible mechanism for prolonged persistence of 
PRRSV following infection (Van Reeth et al., 1999). 
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2.10.2 Adaptive immune response against PRRSV 
2.10.2.1 Humoral immunity response 
The humoral immune response is presumed to play an important role in resistance to 
re-infection and in prevention or reduction of viral spread from animal to animal since 
neutralizing antibodies have the potential to clear virus from the circulation and may provide 
solid protective immunity when are present at the time of viral exposure (Lopez et al., 2007). 
It takes around 3 months to develop protective adaptive immunity against PRRSV during 
natural infection (Mateu & Diaz, 2008). Circulating antibodies against PRRSV are detectable 
in some pigs by days 5-7 p.i. and all animals usually seroconvert by day 14 p.i. (Yoon et al., 
1995b). Following PRRSV infection, there is a rapid rise of PRRSV-specific non-neutralizing 
antibodies (NNAbs), while neutralizing antibodies (NAbs) are detectable only at 3 weeks p.i. 
at very low titers. The earliest and strongest antibody response is directed against the N and M 
proteins which is measurable 5-9 days p.i.  Antibodies directed against the N protein of 
PRRSV are the most abundant during viral infection, but they are non-neutralizing and hence 
do not confer protection against virus infection (Johnson et al., 2004). Neutralizing antibodies 
produced against GP5 protein located in the N-terminal region interferes with the initial step 
of PRRSV infection and is most relevant for protection against PRRSV infection and appear 
by day 21 to 28 p.i. (Loemba et al., 1996; Wissink et al., 2003; Plagemann et al., 2002). On the 
other hand PRRSV specific immunoglobulin (Ig) M appears 5-7 days p.i. after infection and 
decrease to undetectable levels after 2-3 weeks. Anti-PRRSV IgG antibodies are detected 7-10 
days after infection, peak at 4 weeks and then decline to low levels by 300 days p.i. (Loemba 
et al., 1996). Antibody responses are also elicited to nsps of the replicase complex, particularly 
the nsp2 polypeptide (Oleksiewicz et al., 2001). 
2.10.2.2 Cell-mediated immunity response 
Cell-mediated immunity (CMI) is also extremely important. Pigs recovering from 
experimental infection developed lymphocyte proliferative and neutralizing antibodies (NAbs) 
response after 3 weeks p.i. (Bautista & Molitor, 1997). Porcine reproductive and respiratory 
syndrome virus specific T cell responses are transiently induced 2-8 weeks after infection 
(Lopez Fuertes et al., 1999). This response can be detected from day 9 p.i. (Bautista & 
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Molitor, 1997). The circulating T cell phenotype is reported as PRRSV-specific CD4+ and 
CD8+ cells, as well as CD4 and CD8 double-positive cells that are probably memory cells 
(Batista et al., 2004; Bautista & Molitor, 1997). Once these cells appear, their number 
increases only very gradually during weeks to months (Diaz et al., 2005). The change in ratios 
on the population representing T cells CD4+/ CD8+ was observed in infected sows 
(Christianson et al., 1993). During the next weeks, a rise in the CD8+ cell population is 
observed in tonsils and draining lymph nodes of the lungs which are the sites where virus 
often persists for a long time (Albina et al., 1998b; Diaz et al., 2005). In addition, serum 
neutralizing antibodies, IFN-γ specific T cell responses play a significant role in PRRSV 
clearance. Interferon-γ producing lymphocytes are recruited to the lungs after PRRSV 
infection (Thanawongnuwech et al., 2003). However, IFN-γ secreting cells are generally not 
detected earlier than three to four weeks upon PRRSV infection (Diaz et al., 2005; Bautista & 
Molitor, 1997).  
2.11Diagnosis 
 
2.11.1 PCR assays 
Nowadays the use of standard laboratory methods for diagnosis of PRRSV is based on 
different techniques such as viral genome detection and serological testing. Detection of 
PRRSV nucleic acid can be accomplished with reverse-transcription polymerase chain 
reaction (RT-PCR), and more specifically quantitative PCR (Wernike et al., 2012). The 
advantage using real-time PCR is that it is fast, sensitive and can be performed in a large-scale 
setup (high throughput). One of the critical parameters in the PCR technique is the selection of 
the primer pairs, because nucleotide mismatch could lead to false negative results (Kleiboeker  
et al., 2005). Practical problems with the real-time RT-PCR method for detection of PRRSV is 
the high genomic diversity of PRRSV since the sensitivity of the assay rely on the nucleotide 
match between the PRRSV RNA template and the primers and probes used. Due to the high 
genomic diversity of PRRSV, it is difficult to design conserved primers matching for all 
PRRSV strains. A solution to this key problem is the use of mixture of several primer pairs 
and probes to cover a broader range of variant templates (Wernike  et al., 2012). Conventional 
PCR can also be used for the detection of PRRSV. The DNA products obtained from 
conventional PCR can be used for sequencing and phylogenetic analyses. Open reading frame 
 
 
48 
 
5 gene is used on a regular basis for phylogenetic analyses. The type 1 contained a diverse 
assemblage of viruses for which the nucleotide identity of ORF5 varied from 92.4 to 100%. In 
addition, phylogenetic analyses of type 2 ORF5 varied from 86.5 to 100% (Choi et al., 2012; 
Shi et al., 2010a). 
2.11.2 Serological assays 
Serological diagnosis in PRRSV is used for specific antibodies detection. In general, 
the enzyme-linked immunosorbent assay (ELISA) is easy to perform, possesses a good 
specificity and sensitivity, especially on a herd basis. ELISA method is the most commonly 
used in the global swine industry. The ELISA commercial assay most used is the IDEXX 
PRRS X3 Ab test and is considered to be the gold standard ELISA in the detection of PRRSV 
Ab in serum with a sensitivity of 98.8% and a specificity of 99.9% (Sattler et al., 2015). 
ELISA relies on the detection of antibodies against PRRSV that appear by 9-13 days 
p.i., rise to peak values by 30-50 days p.i. and then decline (Table 2) (Desrosiers & Boutin, 
2002; Yoon et al., 1995b). It is important to investigate the impact of dilution of samples (1:2, 
1:4, 1:6, 1:8 and 1:10) on the probability of false negative results and the estimation of pool 
sensitivity and specificity (Kittawornrat et al., 2012; Rovira et al., 2008). The presence of 
PRRSV antibodies is determined by measuring the sample-to-positive ratio (S:P ratio) which 
is corrected for non-specificity, a S:P ratio of 0.4 or greater is considered positive (Yoon et al., 
1995a).  
The ELISA assay offers several advantages for PRRSV testing: it detects both type I 
and type II PRRSV strains, it has rapid results, it is automated and it results in less variation 
(Kittawornrat et al., 2012). Nevertheless, interpretation of samples that test positive and 
negative with ELISA can be difficult. Negative ELISA samples may be misinterpreted as 
coming from uninfected pigs when in fact the pigs had a recent infection but had not 
seroconverted. Pigs may be persistently infected but become seronegative. Pigs that have 
cleared the infection can revert to seronegative. Pigs may also test negative due to the poor 
sensitivity of the test (Yoon et al., 2003). 
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The indirect fluorescent antibody test (IFA) has been used more than 10 years ago, but 
nowadays is no longer used on a regular basis. The IFA have the capacity to detect specific 
antibodies for 2 to 3 months after infection (Yoon et al., 1995b). The presence of a green 
cytoplasmic fluorescence in infected cells combined with the absence of such a signal in non-
infected cells was indicative of the presence of antibodies to PRRSV in the serum at the 
dilution tested (Yoon et al., 2003). IFA specific antibodies IgG against PRRSV appeared by 7-
11 days p.i. and the peak at 30-50 days p.i. (Collins et al., 1996). In addition, PRRSV specific 
IgM antibodies were detected within 5 days p.i. and persisted 14 days p.i. (Table 2) (Collins et 
al., 1996). 
2.11.3 Virus isolation 
Virus isolation is an old technique but not a gold standard test for PRRSV detection 
because PRRSV isolation is fastidious and not sensitive. Porcine reproductive and respiratory 
syndrome virus can be isolated from many tissues including lung, tonsil, and lymph nodes. 
Before isolation, it is important to know that PRRSV retains infectivity for 1 month when 
refrigerated at 4°C and for at least 18 months when frozen at -70°C; however, it is rapidly 
inactivated at 37°C (Snyder, IDEXX Laboratories, 1995). 
A study carried out by Kim et al., (1993) demonstrated that the isolation of PRRSV 
can be done using the MARC-145 cell line, which had supported replication of all 11 different 
PRRSV isolates that were tested.  As well as MARC-145 cells, the primary permissive PAMs 
cells can support PRRSV replication. However, the collection of PAMs is not an easy task and 
only pigs of high health status, less than 8 weeks of age should be used as the source of PAMs.  
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Table 2:  List of porcine reproductive and respiratory syndrome virus (PRRSV) serological 
assays that are used for specific antibodies detection. 
 
Serological 
test 
Antibody 
first 
detected 
Peak 
antibody 
titer 
Decline 
antibody 
titer 
Antibody 
undetectable 
Positive 
titer 
Sensitivity Specificity 
        
Indirect 
fluorescent 
Detects IgG 
7-11 days 
pi 
a
 
30-50 
days pi 
4-6 
months pi 
6 months pi >1:16 or 
>1:20 
b
 
- High
c 
        
Indirect 
fluorescent 
Detects IgM 
5 days pi 
in 3 weeks 
piglets, 7 d 
in sows 
14 days pi >14 days  
pi 
28 days in 
piglets, 21 d 
in sows 
>1:16 or 
>1:20 
b
 
- - 
        
ELISA 
Herdcheck-
PRRS® 
IDEXX 
Laboratories 
9-13 days 30-50 
days 
4 months 
pi 
4>10 months 
pi 
S:P ratio   High 
c
 High
c
 
        
Serum 
Neutralization 
21-28 days 
pi 
60-90 
days 
>3 months 
pi 
>1 year pi >1:4   Low High 
 
a pi= Post infection 
b Depends on the initial dilution used in the IFA test 
c Sensitivity (100%, 35/35 samples) and specificity (99.5%, 413/415 samples) 
Adapted from Michael L. Snyder IDEXX Laboratories Inc. 
2.12 Treatment and prevention 
2.12.1 Biosecurity       
There is no single successful strategy for the control of PRRS, largely because of virus 
genomic variability and swine populations. Treatment is symptomatic and aims to prevent 
secondary bacterial infections. Prior to decide which PRRS control strategy should be used, it 
is crucial to understand the importance of controlling viral circulation in breeding herds. No 
program will be effective if adult swine are spreading the virus among themselves or to their 
piglets. The presence of high IFA titers (1:256– 1:1024) or high ELISA s/p ratio (2.0–4.0) in 
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sera of sows or recently weaned pigs may indicate actively circulating virus in a breeding 
herd, particularly if seroprevalence exceeds 20% (Dee & Joo, 1997). 
The nursery depopulation strategy is used to control PRRSV. It consists of temporary 
adjustment in nursery pig flow to prevent the spread of virus from older, previously infected 
pigs to those recently weaned: 1) depopulate all nurseries at one time; 2) move pigs to another 
site until marketed; 3) do not re-introduce these animals to the primary herd site; 4) wash and 
disinfect all nursery rooms three times using 90-94°C water and a rotation of chemical 
disinfectants (formaldehyde- and phenol-based products);  5) rooms should remain free of pigs 
for a minimum of 2–3 days (Dee & Joo, 1997; Dee & Joo, 1994).  
Nevertheless, it is important to place some limits on the introduction of seed stock into 
the sow herd.  To assure that the replacement gilts are well acclimatized, they must be allowed 
at least 60 days recovery time. Ideally replacement gilts should originate from a single, PRRS- 
negative source. Boars should be quarantined for 60-90 days after purchase, and must be 
negative serologically before they are introduced into PRRSV negative herds. For artificial 
insemination nowadays, many organizations that provide semen use PCR to assure that semen 
is free of PRRS virus (Corzo et al., 2010). 
Once infection occurs, PRRSV can be shed from persistently infected pigs via blood, 
saliva, milk and colostrum, urine and feces, as well as contaminated semen. It was 
demonstrated that people can transmit the virus by using contaminated needles (Otake et al., 
2002). Some important biosecurity intervention must be taken such as shower-in/out, one-
night down time, changing coveralls and boots for visitors and workers and changing needles 
for vaccines. 
PRRSV can be spread to susceptible animals following contact with contaminated 
transport vehicles. Therefore, as with facilities, stringent compliance with 
cleaning/disinfection and drying protocols is critical for sanitizing the trailers of transport 
vehicles. Potential risk points in the cab of the truck (pedals, floor mats) can be effectively 
sanitized using disinfectant spray (Pitkin et al., 2006). 
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Airborne transmission of PRRSV has been studied. It was demonstrated that 
transmission could occur over long distances between 4.7 and 9.1 km (Dee et al., 2009). Air 
filters have been used to control airborne transmission of PRRSV in nucleus herds. These risk 
factors include cool temperatures, the presence of the pathogen in the source population, wind 
direction, low sunlight levels, and low velocity winds in conjunction with gusting and rising 
humidity and pressure (Dee et al., 2010).  
2.12.2 Vaccines 
Due to immune evasion strategies and the antigenic heterogeneity of the virus, current 
commercial PRRSV vaccines (killed-virus and modified-live vaccines) have generally not 
been very successful, partially because of the rapid mutation rate and evolution of the virus, 
lack of cross-protection, and weakness in inducing the ‘correct’ immune response in the 
animal (Hu & Zhang, 2013). Research will help to develop new vaccine strategies against 
PRRSV infection. Experimental PRRSV vaccines, including live attenuated vaccines, 
recombinant vectors expressing PRRSV viral proteins, DNA vaccines and plant-made subunit 
vaccines, have been developed. Nevertheless, protection provided by the conventional 
attenuated live vaccines is better than that from inactivated vaccines and all the other 
experimental new recombinant vaccines that were tested until now (Table 3) (Hu & Zhang, 
2013; Labarque et al., 2003).  
Among commercial attenuated live vaccines against PRRSV, the Ingelvac® PRRSV 
MLV has reduced the incidence and severity of PRRSV outbreaks, helps protect gilts from 
viremia and helps reduce numbers of pre and post-natal death and congenitally infected piglets 
and it is used as a tool for preventing and controlling PRRSV since 1995. This vaccine elicits 
relatively high humoral and cell-mediated immune responses. PRRSV specific antibodies 
appear approximately at 2 weeks and peak around 4 weeks after vaccination. The duration of 
immunity is at least 4 months or throughout the finishing or gestation period 
(Charerntantanakul, 2012). The majority of animals that are infected or immunized will 
produce a large amount of antibodies against the viral nucleocapside (N). However, the 
vaccine may induce neutralizing antibodies and reduce viremia in gilts and help to reduce 
numbers of pre-and post-natal death, and congenital infection in piglets (Kim et al., 2008). 
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Besides, the acute syndrome in pigs has increased enormously around the world producing 
economic losses for about US$560 million (Neumann et al., 2005). For this reason the 
attenuated live vaccine Ingelvac® PRRS ATP has been developed as highly effective 
modified live PRRSV vaccine to control PRRS virus. This vaccine was introduced to swine 
industry in 2000. It is able to induce protection against highly virulent heterologous strains of 
PRRSV (Key et al., 2003).   
On the other hand, Fostera PRRS, is a modified-live PRRSV vaccine. This PRRSV 
vaccine helps to prevent respiratory disease associated with PRRSV with a duration of 
immunity of at least 24 weeks. Fostera PRRS helps optimize performance by minimizing the 
adverse effects of a subsequent PRRSV challenge, reduce levels of viremia and the severity of 
PRRSV lesions, thereby allowing growing pigs to maximize their post-challenge weight gain 
(Park et al., 2014). 
Additionally, others modified live virus vaccines have been developed. For example, 
the attenuated vaccine RespPRRS/Repro (Boehringer Ingelheim) is recommended for use in 3-
18 week-old pigs and in nonpregnant sows (Dee & Joo, 1997). The Prime Pac PRRS vaccine 
(Schering Plough Animal Health Corporation) has been showed to reduce the severity and 
duration of disease. A modified-live-virus (MLV) vaccine, propagated in an innovative 
porcine alveolar macrophage cell line, designated ZMAC cells, was effective in protecting 
pigs against PRRSV. However, the vaccine was more effective than the one generated in 
MARC-145 cells at reducing the extent of infection and also at eliminating virus from the 
lungs at 7 or 10 days post-challenge (Yaeger, 2000). A live vaccine based on PRRSV 
European strain (Porcilis PRRS) was able to stimulate cell mediated immunity and induces a 
faster antibody response, which is necessary to control PRRSV (Mavromatis et al., 1999). 
The Spanish MLV vaccine amervac (Hipra laboratories, Spain) is based on a European 
type strain (5710), belonging to Lelystad-like cluster, isolated in Spain in 1992. This vaccine 
has the potential to provide remarkable virological protection against PRRSV infection, 
reduces dramatically post-challenge viremia and prevents PRRSV dissemination to peripheral 
tissues (Alvarez et al., 2006). 
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Table 3: Recommendation and vaccination schedule of commercial PRRS modified-live virus 
vaccines 
 
 
1 Not recommended for use in porcine reproductive and respiratory syndrome virus-negative 
farms;  
2 Not recommended for use in boars due to negative impact on semen quality;  
3 Recommended to revaccinate every 3-4 months for whole herd vaccination program. i.m: 
Intramuscularly. Adapted from Charentanakul, 2012. 
 
 
 
      VACCINE 
1
            PIGS 
2
 ROUTE DOSE     
(ml) 
               PROGRAM 
     
Fostera PRRS Piglets and older i.m 2 Three weeks and older 
     
Ingelvac® PRRS 
MLV          
Gilt/Sow  
Piglet/Nursey/Growing 
i.m 
i.m 
2 
2 
At any stage of production 
3 
At any stage of production 
3
 
     
ReproCyc®PRRS 
MLV        
Gilt/Sow                         i.m 5 Primary 4-6 wk prior breeding 
     
Ingelvac®PRRS 
ATP            
Nursery/growing i.m 2 At 3-18 wk of age 
     
Porcilis-PRRS® 
 
Subsequent 
breeding              
Gilt/Sow      
 
Piglet/Nursery/Growing 
i.m 
 
i.m/id 
2 
 
2/0.2 
Primary:2-4 wk prior breeding 
Booster:3-4 prior. 
At 2 wk of age or older     
     
Amervac-PRRS®   Gilt/Sow      
 
i.m 2 At 4 wk of age or older 
     
Pyrsvac-183®                        Gilt/Sow        
 
Piglet/Nursery/Growing                           
i.m 
 
i.m/id 
2 
 
2/0.2 
Primary:2-4 wk prior to breeding 
Booster: 3-4 wk subsequent 
At 2-3 wk of age or older                                                                                                                        
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3. Deoxynivalenol and Susceptibility to some infectious diseases 
The capacity of many natural toxins and environmental toxicants to impact host 
immunity involves potential implications relative to the expression of appropriate responses to 
infectious agents. It has been shown that Fusarium toxins such as T-2 toxin affects cellular 
and humoral immune response and provoke decrease of host resistance to infectious diseases. 
Deoxynivalenol, another Fusarium toxin, can upregulate the expression of cytokines and 
produce immunosuppression (Bondy & Pestka, 2000). Deoxynivalenol exposure also 
interferes with immune responses at critical mucosal site such as the respiratory tract and 
gastrointestinal system. According to some reports DON might interfere with the immune 
response to reovirus, a double-strand RNA virus isolated from the respiratory and 
gastrointestinal systems of animals (Nibert et al., 1996). The capacity of DON to modulate 
reovirus respiratory infection was documented. Respiratory reovirus infection caused a mild 
bronchopneumonia in mice which was markedly exacerbated by DON with a severe 
inflammatory cell infiltration, marked alveolar damage and reduced type 1 IFN-mediated 
genes in the lung contributing to DON impairment of pulmonary reovirus clearance (Li, et al., 
2007). The same author investigated the suppressive effects of DON in the immune response 
to enteric reovirus infection. Deoxynivalenol increases the severity of reovirus infection and 
suppresses the host response by modulating cytokine expression (Li, et al., 2005). 
The negative impact of DON on the gut function and immune system together with 
other adverse toxic effects could be an important factor for increasing the susceptibility of 
poultry flocks to infectious diseases. It has been suggested that DON can impair the immune 
function in broilers, by inducing changes in the hematopoietic system of chicks and by altering 
the mitogen-induced proliferation of lymphocytes. Feeding DON contaminated grains to 
chickens decreased the titer of serum antibody against Newcastle disease virus (NDV) and 
infectious bronchitis virus (IBV) (Awad et al., 2013; Ghareeb et al., 2012). Other experiment 
investigated vaccine response against NDV and IBV virus in broiler fed with DON at the 
concentrations of DON 1.68 mg/kg as low diet and 12.209 mg/kg as high diet. Results showed 
that antibody responses to NDV and IBV were lower during week 5 of exposure to the high 
diet of DON (Yunus et al., 2012). Pigs fed with DON at the concentration of 2.2-2.5 mg/kg for 
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9 weeks, did not show a major changes of hematological and biochemical blood parameters 
but had low expressions of transforming growth factor beta (TGF-β) and IFN-. Taken all 
together these data showed that DON could affect directly and indirectly animal immune 
response to  vaccination (Pinton et al., 2008). 
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4. Hypothesis and objectives 
1- Deoxynivalenol alters in vitro cells properties and subsequently could affect PRRSV 
replication efficiency in primary porcine alveolar macrophages (PAM) and MARC-145 cells 
that are permissive to PRRSV replication. The objective of the first part of this study was to 
determine if DON at different concentrations could influence the efficiency of PRRSV 
replication in PAM and MARC-145 cells. 
2- In pig, ingestion of DON-contaminated feed affect growth performance and increase 
disease susceptibility. Ingestion of DON-contaminated feed could exacerbate PRRSV 
infection and worsen its clinical signs. The objective of this second part of the study was to 
evaluate the impact of naturally contaminated diets with DON on virological and 
immunological parameters, clinical signs and lung lesions in growing piglets infected with 
PRRSV. 
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Abstract 
Deoxynivalenol (DON) is a mycotoxin produced by Fusarium spp. Among 
monogastric farm animals, swine are the most susceptible to DON as it markedly reduces feed 
intake and decreases weight gain. DON has also been shown to increase susceptibility to viral 
infections; therefore the objective of this study was to investigate in vitro impact of DON on 
porcine reproductive and respiratory syndrome virus (PRRSV). Permissive cellswere infected 
or not with PRRSV and were treated with increasing concentrations of DON. Cell survival and 
mortality were evaluated by determining the number of viable cells with a tetrazolium 
compound and by measuring lactate dehydrogenase (LDH) release, respectively. Virus 
titration and antiviral cytokines mRNA expression were evaluated by quantitative PCR. DON 
significantly affected the survival of noninfected cells in a dose dependentmanner. However, 
DON concentrations between 140 and 280 significantly increased the survival of cells infected 
with PRRSV. These concentrations significantly decreased PRRSV replication by inducing a 
pro-inflammatory cytokines environment and an early activation of apoptosis, which in turn 
seem to interrupt viral replication. For the first time, this study showed that DON had 
significant effects on the survival of PRRSV infected cells and on virus replication, in a dose 
dependent manner. 
Key words: Deoxynivalenol, PRRSV, in vitro, virus replication, swine. 
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1- Introduction  
Deoxynivalenol (DON) is a trichothecene mycotoxin produced by many Fusarium spp 
mold, often found in feed and other organic substrates. DON is a major contaminant of cereal 
grains such as wheat, barley and corn (Binder et al., 2007). Among farm animals, pigs show a 
great sensivity to DON, and because of the high proportion of grains in their diets, pigs are 
frequently exposed to this mycotoxin (D'Mello et al., 1999). DON usually enters the body via 
oral route and subsequently encounters intestinal epithelial cells, which represent the primary 
target for alimentary intoxication. Once absorbed, DON decreases cell protein synthesis and 
impairs immune system cells that appear to be especially sensitive (Pestka, 2008). 
Studies in farm and laboratory animals reveal that DON elicits a complex spectrum of 
toxic effects. Upon acute exposure to high concentrations, animal exhibits a “radiomimetic” 
shock-like response that includes diarrhea, vomiting, leukocytosis and haemorrhage, with 
extremely high concentrations can result in death (Ueno, 1984). Chronic exposure to DON can 
cause anorexia, reduced weight gain, diminished nutritional efficiency, and immune 
modulation (Rotter et al., 1996). One study reported that pigs fed diets containing 2 and 4 
mg/kg of DON exhibited a dose-related decrease in weight gain within the first 8 weeks 
(Bergsjø et al., 1992). In addition, the immune system is particularly sensitive to DON and can 
be either stimulated or suppressed depending on doses, exposure frequency, timing and the 
functional immune assay being employed. Leukocytes, most notably mononuclear phagocytes, 
play a likely central role in the acute and chronic toxicity evoked by DON. Low 
concentrations of DON induce expression of an early proinflammatory response at mRNA and 
protein levels, while high concentrations promote rapid onset of leukocyte apoptosis (Pestka 
and Amuzie, 2008). 
As classically observed for many trichothecenes, DON inhibits protein synthesis in 
vivo and in vitro. The mechanism for translation inhibition by DON and other trichothecenes 
involves interference with peptidyl transferase function on ribosome with consequent 
impairment of initiation and elongation (Shifrin and Anderson, 1999). Moreover, DON 
induces the activation of mitogen-activated protein kinases (MAPKs) and extracellular signal-
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regulated kinase (ERK) in macrophages and monocytes mediating upregulation of 
proinflammatory cytokines expression as well as apoptosis (Pestka, 2010).  
In cases of mycotoxin-induced immunosuppressive effects on cellular and/or humoral 
immune responses a concomitant decrease in host resistance to infectious diseases has been 
reported (Oswald et al., 2005). In mice, consumption of feed contaminated with T-2 toxin, 
another trichothecene, increased the susceptibility to Herpes simplex virus-1 (HSV-1) 
infection, by allowing virus proliferation, ultimately resulting in the death of mice naturally 
resistant to HSV-1 (Friend et al., 1983). Other studies in mice suggests that DON 
compromised resistance to enteric (Li et al., 2005) and respiratory (Li et al., 2007) reovirus 
infection.  
Porcine reproductive and respiratory syndrome (PRRS) is one of the most 
economically important porcine infectious disease worldwide (Neumann et al., 2005). PRRS is 
caused by a virus (PRRSV) that was first isolated from tissues of piglets and from blood 
samples of sows affected by PRRS in 1991 in the Netherlands using porcine alveolar 
macrophages (Wensvoort et al., 1991) and later in North America (Collins et al., 1992). On the 
basis of similar morphology, genomic organization, replication and transcription strategy, and 
protein composition, PRRSV is classified in the genus Arterivirus, which belongs to the 
Arteriviridae family within the order of Nidovirales (Cavanagh, 1997). PRRSV is an 
enveloped virus containing a positive strand RNA genome of approximately 15k nucleotides. 
PRRSV causes severe reproductive impairment in breeding animals and respiratory problems 
in pig of all ages (Music and Gagnon, 2010). The virus infects a specific subset of 
macrophages; alveolar macrophages in pigs (Duan et al., 1997). In vitro, primary porcine 
alveolar macrophages (PAM) and MARC-145 cells are known to be susceptible to the virus 
(Mengeling et al., 1995). Since DON is frequently encountered in pig diets, its presence could 
exacerbate viral infections such as PRRSV. Currently, there is no in vitro model that can 
determine the impact of DON on PRRS infection at the cellular level. Therefore, the objective 
of this study was to evaluate the in vitro effect of DON in PRRSV infected cells.  
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2- Materials and methods 
2.1 Cells and Virus 
All cell culture products were purchased from Life technologies (Burlington, ON, 
Canada) unless otherwise specified. MARC-145 cells, known to be permissive to PRRSV 
(Kim et al., 1993), were grown in MEM medium supplemented with 5 U/ml penicillin, 5 
µg/ml streptomycin, 2.5 µg/ml fungizone (Wisent inc. St-Bruno, QC, Canada), 10 mM 
HEPES and 10% fetal bovine serum (FBS) (Wisent inc., St-Bruno, QC, Canada). Cell viability 
was evaluated by trypan blue exclusion technique and cells were adjusted to a final 
concentration of 2.5X10
5
 viable cells/ml. A volume of 100 µl/well was then plated into 96-
well microtiter plates and incubated at 37°C for 24 h in a humidified 5% CO2 incubator. 
All experiments involving pigs were conducted in accordance with the guidelines and 
policies of the Canadian Council on Animal Care. PAM cells were obtained from broncho-
alveolar lavage of 42 to 70 day old PRRSV-negative piglets. Two days prior the lavage, 
piglets were injected with 4 ml/kg of tylosin (Tylan®200, Elanco, Greenfield, IN, USA). 
Piglets were anesthetised by intramuscular injections of 2 mg/kg of azaperon (Stresnil, Janssen 
pharmaceutica, Beerse, Belgium), 2 mg/kg xylazine (Xylamax, Bimeda-MTC animal health, 
Cambridge, ON, Canada) and 20 mg/kg ketamine (Vetalar, Bioniche animal health, Belleville, 
ON, Canada) and sacrificed by intravenous overdose of sodium pentobarbital (Eutanyl Forte 
540, Bimeda-MTC animal health, Cambridge, ON, Canada). Lungs were then removed and 
washed with 500 ml of sterile phosphate buffer saline solution (PBS) supplemented with 5 
U/ml penicillin, 5 µg/ml streptomycin and 100 µg/ml gentamicin. Broncho-alveolar lavage 
fluid was centrifuged at 400 × g for 10 min, washed in PBS and cell pellets were resuspended 
in DMEM with 20% FBS, 2 mM L-glutamine, 10 mM HEPES, 1% essential amino acids, 5 
U/ml penicillin, 5 μg/ml streptomysin sulfate, 100 μg/ml gentamycin, 2.5 µg/ml fungizone and 
10% DMSO. Cell concentration was adjusted to 1x10
7
 cells/ml and cells were stored frozen in 
liquid nitrogen until use. Prior to experiment, cells were thawed, washed twice in 20 ml of 
DMEM and resuspended in DMEM supplemented as above except without DMSO. Viable 
cell count was determined by trypan blue exclusion and cells were adjusted to a final 
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concentration of 1x10
6
 viable cells/ml. A volume of 100 µl/well was then plated into 96-well 
plates and incubated for 24 h at 37°C in a humidified 5% CO2.  
Viral stock used for this study was Quebec reference PRRSV strain, IAF-Klop 
(Mardassi et al., 1995) and European reference strain LV (Wensvoort et al., 1991). Virus 
production, titrations and titre calculations (TCID50 values) were performed following 
infection of MARC-145 cells as previously described (Gagnon et al., 2008). 
2.2 Viral infection and DON treatment  
After 24 h of cell incubation, the medium was replaced by a medium containing an 
infectious dose of 0.5 MOI and 1 MOI of PRRSV for MARC-145 and PAM cells, 
respectively. As control, medium alone was added for noninfected treatments. After 3 h 
incubation, the medium was removed again and cells were treated with increasing 
concentrations of DON (Biopure, Tulln, Austria); 70, 140, 280, 560 and 1200 ng/ml and were 
incubated for 72 h. Cell viability and mortality were then determined. Medium alone was 
added as control, since methanol concentration used for DON-dilution stock has no effect on 
different assays (data not shown). Each treatment was performed in triplicate.  
2.3 Determination of cell viability 
Cell viability was measured with CellTiter 96® Aqueous One Solution Cell 
Proliferation Assay (Promega, Madison, WI, USA) at 72 h p.i. To this aim, 20 µl of the 
CellTiter 96® Aqueous substrate were added to the cells and additionally incubated for 1 h at 
37°C in a humidified 5% CO2. Absorbance was measured at 490 nm with a Synergy
TM
 HT 
multi-detection microplate reader (Biotek, Winooski, VT, USA). 
2.4 Determination of cell mortality 
Based on LDH release, cell mortality was measured using CytoTox 96® Non-
Radiactive Cytotoxicity Assay (Promega, Madison, WI, USA) at 72 h. A volume of 50 µl of 
supernatant was transferred to a new 96-well plate. Then 50 µl of the reconstituted substrate 
mix was added to each well, plate was covered and incubated at room temperature in the dark 
for 30 min. Finally, 50µl of the stop solution was added to each well and absorbance was 
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taken at 490 nm as above. For the estimation of maximal releasable LDH, remaining cells 
were lysed by adding 100 l of distilled water and scrapping using a pipette tip. Maximal 
releasable LDH was calculated as the sum of LDH detected in the cell culture supernatant of 
non-treated cells and LDH released after induced lysis of remaining cells. Medium alone was 
used as control of LDH activity. Data were expressed as mortality rate (%), which was 
calculated as follows; [(treatment measured LDH activity - LDH activity of control) / 
(maximal releasable LDH activity - LDH activity of control)]×100.  
2.5. Detection of viral antigen by immunofluorescence 
Presence of PRRSV antigen in infected cells was determined by immunofluorescence 
assay. Briefly, cells infected and treated as in section 2.2 were fixed and permeabilized at 72 h 
pi with a 50% methanol / 50% acetone solution. Noninfected cells were included as negative 
control. After 30 min incubation at room temperature, the methanol/acetone solution was 
removed and cells were washed three times with PBS. Then, α7 rabbit monospecific antisera, 
a specific anti-N PRRSV protein antibody (Gagnon et al., 2003) was diluted 1/200 in PBS and 
added to the cells and incubated at room temperature for 90 min. Cells were then washed and 
incubated for 60 min with 1/75 dilution of anti-rabbit specific antisera FITC conjugated in 
PBS. Finally, cells were visualized using a DMI 4000B reverse fluorescence microscope, 
images were taken with a DFC 490 digital camera and analyzed using Leica Application Suite 
Software, version 3.8.0 (Leica Microsystems Inc., Richmond Hill, Canada). 
2.6. Determination of virus titers by quantitative PCR 
To determine virus titer after DON treatment, cells were infected and treated as 
described in section 2.2. After 72 h pi, viral RNA was extracted as previously described 
(Gagnon et al., 2008). Virus detection was performed using a commercial PRRSV real-time 
PCR diagnostic kit (Tetracore, Rockville MD, USA). Quantification of PRRSV was 
determined by comparing sample results to a standard curve based on the amount of serially 
diluted IAF-Klop PRRSV reference strain (Gagnon et al., 2003) titrate after infection of 
MARC-145 cells and expressed as TCID50/ml. 
2.7. Cytokine mRNA expression 
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Cytokine mRNA expression was determined in PAM cells. The cells were prepared in 
6-well plates to a final concentration of 1x10
6
 viable cells/ml in 1.5 ml of medium; then the 
plates were incubated in a humidified incubator 5% CO2 for 24 h. The medium was removed 
and fresh medium was added containing 1 MOI of IAF-Klop virus strain. As negative control, 
medium alone was added for noninfected cells. Infected and noninfected cells were incubated 
for 3 h, then medium was removed and cells were treated with media containing 0, 280, or 
1200 ng/ml of DON for 3 h. Total RNA from samples was isolated using Quiagen RNeasy 
Mini Kit (Quiagen, Toronto, ON, Canada) according to manufacturer’s instructions. Extracted 
RNA was resuspended in 30 µl of Rnase free water. Total RNA from samples was stored at -
80° until RT transcription. Quantification of RNA was performed with a Nanodrop 
(NanoDrop Technologies, Inc., Wilmington, Delaware, USA). One μg of total RNA was 
reverse-transcribed using the QuantiTect reverse transcription kit (Qiagen, Mississauga, ON, 
Canada) according to manufacturer’s instructions. The cDNA was amplified using the 
SsoFast™ EvaGreen® Supermix kit (Bio-rad, Hercules, CA, USA). The PCR amplification 
program for all cDNA consisted of enzyme activation step of 3 min at 98°C, followed by 40 
cycles of denaturing step for 2 sec at 98°C and annealing/extension step for 5 sec at 58°C. The 
primers used for amplification of different cDNA target are presented in Table 1. All primers 
were tested to achieve amplification efficiency between 90% and 110% (data not shown). The 
primer sequences were all designed from the NCBI GenBank mRNA sequences using web-
based software primerquest from Integrated DNA technologies. Bio-Rad CFX-96 sequence 
detector apparatus was used for the cDNA amplification. Quantification of differences 
between groups was calculated using the 2
-ΔΔCt
 method. β2-microglobulin was used as 
normalizing gene to compensate for potential differences in cDNA amounts. Noninfected 
PAM cells were used as a calibrator reference in the analysis. 
2.8. Caspase-3 activation 
Apoptosis was also assessed by detecting procaspase 3 activation. PAM cells were 
prepared in 6-well plates as described above. As positive control, cells were treated with a 
cocktail of known apoptosis inductor containing 20 g/ml of cycloheximide, 0.5 g/ml 
actinomycin D and 2 g/ml vinblastin sulfate (all from Biomol International, LP, Plymouth 
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meeting PA, USA). At 3 and 6 h post-treatment, cells were disrupted in a cell lysis solution 
(50 mM HEPES, 100 mM NaCl, 0.1% CHAPS 1 mM DTT 100 M EDTA, pH 7.4). Before 
the assay, protein concentration of lysate was determined by Bradford assay (Bio-rad, 
Mississauga, On, Canada) according to manufacturer’s instructions. For the assay, 50 μg of 
cell lysates total protein were diluted in assay buffer (50 mM HEPES, pH 7.4, 100 mM NaCl, 
10% glycerol, 0.1% CHAPS, 100 M EDTA and 10 mM DTT) to adjusted volume to 90 μl. 
Then, 10 μM of specific substrate for caspase 3, Ac-DEVD-AFC fluorogenic substrate (Enzo, 
life sciences, Farmingdale, NY, U.S.A.), was added and the rate of fluorescence released was 
monitored with a 96-well plate fluorescence reader (Biotek, Winooski, VT, USA). Results 
were expressed as relative fluorescence released (relative fluorescence units or RFU) per 
second per μg of cell lysates. 
2.9. Statistical analysis 
All statistical analyses were performed using GraphPad Prism software (version 4.03, 
GraphPad Prism software Inc., San Diego, CA). Data were analysed statistically by 
application of a one-way ANOVA with tukey multiple comparison test. For viability and 
mortality measurement, means of noninfected versus infected cells were compared by 
applying Student′s unpaired ′t′ test, for each DON concentration. P< 0.05 was considered 
reflecting statistically significant differences. Data labeled with superscripts of different letters 
indicate significant difference between data sets. 
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3- Results 
3.1- Effects of DON on cell viability 
Effect of DON was evaluated on PRRSV permissive cells (MARC-145 and PAM) 
using increasing concentrations of DON 70, 140, 280, 560, 1200 ng/ml. Cells were treated for 
72 h and their viability was evaluated. Results showed that DON concentrations of 560 ng/ml 
or higher were significantly detrimental to the survival of MARC-145 and PAM cells at 72 h 
(Fig. 1A and B). For MARC-145 cells (Fig. 1A), a decrease of absorbance in non-treated cells 
was observed compared to DON-treated cells, even though cell morphology appeared to be 
normal under light microscopy (Sup. 1A) suggesting a nonlinearity of the assay. This could be 
explained by the fact that different cell types have different levels of metabolic activity. Many 
factors may affect the metabolic activity of cells that consequently affect the relationship 
between cell number and absorbance. For example, anchorage-dependent cells such as 
MARC-145 that undergo contact inhibition may show a change in metabolic activity per cell 
at high densities, resulting in a nonlinear relationship between cell number and absorbance 
(Cory et al., 1991).  
Viability of cells infected with PRRSV has also been evaluated with aforementioned 
conditions. The viability of noninfected (Fig. 1A, 0 ng/ml DON) and infected MARC-145 
cells, not treated with DON were similar, even if cytopathic effect was observed under light 
microscopy (Sup 1B). However, a significant (P 0.001) reduction of viable cells was found 
in PRRSV infected PAM cells (Fig. 1B, 0 ng/ml DON) without DON due to the virus 
cytopathic effect compared to noninfected cells. In contrast, there was a significant increase of 
viable cells at DON concentrations within 140 to 280 ng/ml and 70 to 280 ng/ml ranges for 
MARC-145 (Fig. 1A) and PAM (Fig. 1B) cells, respectively. These results indicate that DON 
concentrations between 140 and 280 ng/ml could significantly reduce the cytopathic effect 
caused by PRRSV. As for noninfected cells, DON concentrations at 560 ng/ml and higher 
decreased the number of viable cells.  
3.2- Effects of DON on cell mortality 
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In order to solve the nonlinearity of viability assay for MARC-145 cells and to confirm 
the results of cell viability, cell mortality was evaluated using LDH release as indicator of cell 
membrane integrity, 72 h following the same DON treatment. As for the viability assay, only 
high concentrations of DON increased mortality of MARC-145 cells (Fig. 2A). PAM cells 
appeared to be more sensitive to DON than MARC-145 cells, as concentrations of 280 ng/ml 
and higher of the toxin were sufficient to significantly increase LDH release by these cells 
(Fig. 2B). 
As expected, PRRSV infected MARC-145 and PAM cells without DON (Fig. 2A and 
B, 0 ng/ml DON) had higher (P  0.001) mortality rate than their noninfected counterparts, 
because PRRSV is a cytopathic virus. Exposure to low concentration of DON progressively 
decreased mortality of infected MARC-145 cells (Fig. 2A) starting at 70 ng/ml and reaching 
basal level at 140 ng/ml or higher. DON concentration required to decrease mortality of 
infected PAM cells was slightly higher than for MARC-145 cells, at 140 ng/ml and 280 ng/ml 
(Fig. 2B). Since PAM cells appeared to be more sensitive to DON toxicity than MARC-145 
cells, the mortality rate increased again with concentrations over 280 ng/ml. These results 
confirm those obtained with cell viability, that DON concentrations between 140 and 280 
ng/ml could significantly reduce PRRSV cytopathic effect. These results do not seem related 
to viral genotype, since similar results were obtained with reference European strain LV (Sup. 
2).  
3.3- Effects of DON on PRRSV viral replication 
To test DON effect on PRRSV replication, immunofluorescence experiment was 
performed to detect PRRSV N antigen in MARC-145 infected cells treated with DON. Results 
showed that the staining of PRRSV gradually decreased starting at 140 ng/ml of DON until 
complete disappearance of labeling at 560 ng/ml or higher (Fig. 3A). In order to confirm this 
result, the experiment was performed in PAM cells, the natural target cell of the virus. Cell 
pellet and supernatant were subjected to a quantitative PCR assay to determine virus titer. 
Results demonstrated that PRRSV titer gradually decreased starting at 140 ng/ml of DON until 
reaching basal level at 280 ng/ml or higher (Fig. 3B). Taken all together, these results suggest 
that DON could inhibit PRRSV replication in a dose dependent manner, which may explain 
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the decrease in cell mortality caused by DON in infected cells, since the replication of virus 
was affected. 
3.4 Effect of DON on antiviral and pro-inflammatory cytokines expression 
Relative mRNA expression of some antiviral (IFN-α and IFN-β) and pro-inflammatory 
(IL-6 and TNF-α) genes were measured in PAM cells following exposure to increasing doses 
of DON (0, 280 and 1200 ng/ml). Relative mRNA expression of the same genes were also 
measured on PRRSV infected PAM cells exposed to same concentrations of DON (Fig. 4). 
Results demonstrated that the relative expression of all tested cytokines mRNA were 
upregulated only with the highest DON dose, 3 h following exposition to DON alone. 
However, the increased expression of antiviral cytokines mRNAs (Fig. 4A and B) was 
significantly offset by PRRSV infection, which is not the case for pro-inflammatory mRNA 
such as IL-6 and TNF-(Fig. 4C and D).  
3.5 Effect of DON on caspase-3 activation 
Exposure to DON is also known to induce apoptosis, which could also contribute to 
the inhibitory effect of DON on PRRSV. Apoptosis is characterized by morphological and 
biochemical changes, including caspases activation. In order to evaluate apoptosis triggering, 
caspase-3 like activity was measured. Results showed that caspase-3 activation was increased 
in a dose dependent manner, 3 h and 6 h after DON exposition (Fig. 5A and B). Only 1200 
ng/ml of DON has increased significantly caspase-3 activity however at 6 h pi, this activity 
has significantly increased also for 280 ng/ml of DON in PRRSV infected cells (Fig. 5B). As 
for pro-inflammatory genes, the increase of caspase-3 activation was not significantly changed 
by PRRSV infection. 
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4- Discussion 
Contamination of cereal intended for pigs feeding by toxins produced by various molds 
and fungi is a major problem for livestock production. Among these toxins, DON has drawn 
more attention because of it high occurrence frequency at high concentrations (Glenn, 2007). 
Pigs exposed to feed contaminated with 20 mg/kg of DON have usually acute toxic effect such 
as vomiting (Young et al., 1983). On the other hand, low concentration of DON such as 1 
mg/kg can lead to reduced feed intake and weight gain (Rotter et al., 1994). In addition, DON 
is also known to possess immunomodulatory properties, since high concentrations may result 
in immunosuppression, characterized by a decrease in circulating lymphocytes while low 
concentrations can induce stimulation of cytokine and inflammation associated genes (Pestka 
and Smolinski, 2005). As a consequence, DON and other fusarium toxins have been shown to 
increase susceptibility to viral infections in various animal models (Danicke et al., 2011; 
Friend et al., 1983; Li et al., 2007; Li et al., 2005). 
At cellular level, toxic effect of DON is mainly due to inhibition of protein synthesis 
(Ueno et al., 1973). At molecular level, mechanism of action of DON includes activation of 
MAPKs and ERK, known to be critical for signal transduction in the immune response (Islam 
et al., 2006; Zhou et al., 2003). In turn, these MAPKs mediate upregulation of 
proinflammatory cytokine and chemokine expression as well as apoptosis (Chung et al., 2003; 
Moon and Pestka, 2002). The analysis of cell viability and mortality presented in this study 
showed that DON concentrations of 560 ng/ml and higher were significantly detrimental to the 
survival of MARC-145 and PAM cells. These toxic concentrations were similar to those 
previously observed for primary porcine cells (Doll et al., 2009; Goyarts et al., 2006) where 
IC50 values were estimated at 503 and 309 ng/ml for primary macrophages and peripheral 
blood lymphocytes respectively. Several recent reports indicate that DON induces 
programmed cell death via extrinsic and intrinsic apoptotic pathways (Bensassi et al., 2012; 
He et al., 2012; Ma et al., 2012). As expected, caspase-3 activation observed in our 
experiments strongly suggests that cells exposed to DON probably die by apoptosis. 
PRRSV is considered as one of the most important swine pathogens. In vivo, the virus 
is known to infect subsets of pig macrophages that are mainly present in lungs and lymphoid 
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organs (Duan et al., 1997). In vitro, PRRSV infects primary cell cultures of PAM (Wensvoort 
et al., 1991) and monkey cell lines such as MARC-145 (Kim et al., 1993), the two models 
selected for this study. In both, PAM and MARC-145 cell models, PRRSV causes observable 
cytopathic effects between 48 h to 72 h pi. Cell viability and mortality showed a rapid cell 
death caused by PRRSV strains used in this study. Interestingly, exposure to sub-toxic DON 
reduced significantly cell mortality triggered by PRRSV, in a dose dependent manner. Our 
data also showed that specific PRRSV antigen content of infected cells was reduced as seen in 
the immunofluorescence experiment. This result was confirmed by qPCR indicating a lower 
amount of PRRSV genes after DON exposure. These results suggest that DON doses between 
140 and 280 ng/ml could inhibit PRRSV replication which may explain decreased cell 
mortality caused by DON in infected cells. To our knowledge, this study is the first to report 
an inhibitory effect of DON on viral replication at cellular level. Conversely previous report 
by Li and coauthors (2007) demonstrated an in vivo exacerbation of reovirus infection 
following exposure of DON. 
As previously mentioned, DON is known to mediate upregulation of proinflammatory 
cytokine expression as well as apoptosis (Pestka, 2010). Previous study with PAM cells, 
showed that mRNA expression of inflammatory cytokines peaked quickly, 3 h post-exposure, 
and declined progressively to baseline at 12 h post-exposure (Doll et al., 2009). The analysis 
of gene expression showed an increase in the expression of type I IFN (-α, -β), IL-6, and TNF-
α at 3 h in noninfected cells. Data also demonstrated that PRRSV could offset the increase of 
relative expression of type I IFN. Secretion of type I IFNs is a key step in innate immune 
response to viral infection (Kawai and Akira, 2006). Previous studies have demonstrated that 
PRRSV infection results in low type I IFN levels suggesting that PRRSV evolves a strategy to 
interfere with type I IFN signaling pathways, and subsequently to evade innate immune 
response (Albina et al., 1998). A recent review described multiple strategies used by PRRSV 
for manipulating IFN type I response (Sun et al., 2012). Apoptosis is also considered to be an 
important host defense mechanism that interrupts viral replication and eliminates virus-
infected cells (Thomson, 2001). Other study has shown that PRRSV stimulates anti-apoptotic 
pathways in macrophages early in the infection and that PRRSV-infected macrophages die by 
apoptosis later. PRRSV confers protection to infected macrophages against staurosporine-
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induced apoptosis (Costers et al., 2008),but it does not seems to be the case for DON-induced 
apoptosis. In the light of our results, the early activation of pro-inflammatory genes and 
apoptosis following DON exposure appears to be detrimental to PRRSV survival in MARC-
145 and PAM cells.  
Whereas mycotoxin concentration in feed is easily measured, exposure of various 
organs, such as lung, to mycotoxins is more difficult to predict. DON was shown to be rapidly 
and nearly completely absorbed, highly distributed, but poorly metabolized in pigs (Goyarts 
and Danicke, 2006; Prelusky et al., 1988), resulting in high systemic availability. However, 
DON is rapidly excreted in urine which has been shown to be the main excretory route of this 
toxin (Goyarts and Danicke, 2006). Studies over a wide range of DON concentrations in feed 
demonstrated a linear dose relationship to serum concentration; with a very high inter-
individual variation (Danicke et al., 2008). Concentration of DON decreased from bile  
kidney serum  liver = muscle. Plasma median of DON concentration in pigs expose to 2 
mg/kg of DON in feed was reported between 10 to 15 ng/ml (Danicke et al., 2010). Yet, no 
study has linked in vitro effect of DON to concentrations that can predispose pigs to viral 
infections. It is difficult though to predict the degree of exposure necessary for DON to exert 
its inhibitory effect on PRRSV replication. Experiments will be needed to confirm the impact 
of DON-naturally contaminated feed on PRRSV infected animals. 
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Figure 1 
 
Fig.9. Effect of DON on cell viability following PRRSV infection. 
Noninfected or PRRSV (IAF-Klop) infected MARC-145 (A) or PAM (B) cells were 
simulteanously treated with increasing concentrations of DON (0, 70, 140, 280, 560 or 1200 
ng/ml). Cell viability was measured with CellTiter 96® AQueous One Solution Cell 
Proliferation Assay (Promega) 72 h following DON treatment. Data labeled with superscripts 
of different letters indicate significant difference between data sets (P 0.05). * (P 0.05), ** 
(P 0.01), *** (P  0.001), compare noninfected with infected cells at respective DON 
concentration. Results are representative of three independent experiments for each cell types. 
  
 
 
78 
 
Figure 2 
 
Fig.2. Effect of DON on cell mortality following PRRSV infection. 
Noninfected  or PRRSV (IAF-Klop) infected MARC-145 (A) or PAM (B) cells were treated 
simulteanously with increasing concentrations of DON (0, 70, 140, 280, 560 or 1200 ng/ml). 
Cell mortality was evaluated by LDH release, with CytoTox 96® Non-Radioactive 
Cytotoxicity Assay (Promega) 72 h following DON treatment. Data labeled with superscripts 
of different letters indicate significant difference between data sets (P 0.05). *** (P  0.001), 
compare noninfected with infected cells at respective DON concentration. Results are 
representative of three independent experiments for each cell types.  
  
 
 
79 
 
Figure 3 
A) 
 
B) 
 
Fig.3. Effect of DON on PRRSV replication. 
PRRSV (IAF-KLOP) infected MARC-145 cells were simulteanously treated with increasing 
concentrations of DON (0, 70, 140, 280, 560 or 1200 ng/ml) for 72 h. A) PRRSV viral titers 
were measured by immunofluorescence with a PRRSV N-specific antibody. B) PRRSV 
infected PAM cells were simulteanously treated with the same concentrations of DON for 72 
h. PRRSV viral titers were measured, in triplicatas, by qPCR. Data labeled with superscripts 
of different letters indicate significant difference between data sets (P 0.05). 
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Figure 4 
 
Fig.4. Cytokine mRNA expression by qPCR.Noninfected or PRRSV (IAF-KLOP) infected 
PAM cells from 3 different pigs were treated with increasing concentrations of DON 
mycotoxin (0, 280, or 1200 ng/ml) for 3 h. The relative mRNA expression of some antiviral 
IFN-α (A) and IFN-β (B) and pro-inflammatory genes IL-6 (C) and TNF-α (D) genes were 
measured by quantitative PCR. The data is expressed in ΔΔCt using the β2-microglobulin gene 
as the normalizing gene and the noninfected cells as the calibrator reference. Data labeled with 
superscripts of different letters indicate significant difference between data sets (P 0.05). 
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Figure 5 
 
Fig.5. Caspase 3 activation. Noninfected or PRRSV (IAF-KLOP) infected PAM cells, from 3 
different pigs, were treated with increasing concentrations of DON mycotoxin (0, 280, or 1200 
ng/ml) for 3 h (A) or 6 h (B). As positive control, cells were treated with a cocktail of known 
apoptosis inductor containing 20 g/ml of cycloheximide, 0.5 g/ml actinomycin D and 2 
g/ml vinblastin sulfate. The results are expressed as relative fluorescence released (relative 
fluorescence units or RFU) per second per μg of cell lysates. Data labeled with superscripts of 
different letters indicate significant difference between data sets (P 0.05). 
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Supplementary data 1 
 
Supplementary data 1. Morphology of noninfected and PRRSV infected MARC-145 cells 
under light microscopy. 
Noninfected (A) or PRRSV (IAF-KLOP) infected (B) MARC-145 cells, not treated with 
DON, were visualized under light microscope. 
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Supplementary data 2 
 
Supplementary data 2: Effect of DON on cell mortality following PRRSV infection: Effect of 
genotype. 
Noninfected or PRRSV (LV) infected MARC-145 cells were simulteanously treated with 
increasing concentrations of DON mycotoxin (0, 70, 140, 280, 560 or 1200 ng/ml). Cells 
mortality was evaluated by LDH release, with CytoTox 96® Non-Radioactive Cytotoxicity 
Assay (Promega), 72h following DON treatment. Data labeled with superscripts of different 
letters indicate significant difference between data sets (P 0.05). ** (P 0.01), *** (P  
0.001), compare noninfected and infected cells at respective DON concentration. 
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Table 1 : Primers used for the evaluation of cytokine mRNA expressions. 
Cytokine Primers set 
IL-6 F: 5’-ACTCCCTCTCCACAAGCGCCTT-3’ 
R: 5’-TGGCATCTTCTTCCAGGCGTCCC-3’ 
IFN-α F: 5’-CTGCAATGCCATCTACTCTC-3’ 
R: 5’-GGAATCCAAAGTCCCTTCTG-3’ 
IFN-β F: 5’-CTCTCCTGATGTGTTTCTCC-3’ 
R: 5’-GTTCATCCTATCTTCGAGGC-3’ 
TNF-α F: 5’-GCCCACGTTGTAGCCAATGTCAAA-3’ 
R: 5’-GTTGTCTTTCAGCTTCACGCCGTT-3’ 
B2M F: 5’-CGTGGCCTTGGTCCTGCTCG-3’ 
R: 5’-TCCGTTTTCCGCTGGGTGGC-3’ 
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Abstract 
Deoxynivalenol (DON), also known as vomitoxin, is the most prevalent type B 
trichothecene mycotoxin worldwide. Pigs show a great sensitivity to DON, and because of the 
high proportion of grains in their diets, they are frequently exposed to this mycotoxin. The 
objective of this study was to determine the impact of DON naturally contaminated feed on 
porcine reproductive and respiratory syndrome virus (PRRSV) infection, the most important 
porcine viral pathogens in swine. Experimental infections were performed with 30 animals. 
Piglets were randomly divided into three groups of 10 animals based on DON content of diets 
(0, 2.5 and 3.5 mg/Kg DON). All experimental groups were further divided into subgroups of 
6 pigs and were inoculated with PRRSV. The remaining pigs (control) were sham-inoculated 
with PBS. Pigs were daily monitored for temperature, weight and clinical signs for 21 days. 
Blood samples were collected and tested for PRRSV RNA and for virus specific antibodies. 
Results of PRRSV infection showed that ingestion of diet highly contaminated with DON 
greatly increases the effect of PRRSV infection on weight gain, lung lesions and mortality, 
without increasing significantly viral replication, for which the tendency is rather directed 
towards a decrease of replication. These results suggest that PRRSV infection could 
exacerbate anorectic effect of DON, when ingested in large doses. Results also demonstrate a 
DON negative effect on PRRSV-specific humoral responses. This study demonstrate that high 
concentrations of DON naturally contaminated feed decreased the immune response against 
PRRSV and influenced the course of PRRSV infection in pigs. 
Keywords:  Pig; DON mycotoxin; PRRSV; predisposition to infection  
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1. Introduction 
Various commodities for animal feeding are frequently contaminated with mycotoxins 
produced by the secondary metabolism of diverse strains of filamentous fungi. Among them, 
Fusarium spp. are the most prevalent mycotoxin producing fungi in temperate regions (Binder 
et al., 2007). Several toxins are produced by Fusarium spp. including trichothecenes 
deoxynivalenol (DON), nivalenol, and T-2 toxin. Fusarium spp. also produces other toxins 
such as zearalenone (ZEA), fumonisin B1 (FB1), beauvericin and enniatins (Glenn, 2007). 
Consequently, Fusarium spp. naturally infected cereals are frequently contaminated with low 
levels of several different mycotoxins (Binder et al., 2007). 
DON, also known as vomitoxin, is the most encountered mycotoxin contaminating 
cereal worldwide including Canada (Tran et al., 2012). Among farm animals, pigs are the most 
sensitive animals to DON; dietary concentrations between 2 to 5 mg DON/kg are frequently 
associated with feed refusal and concentrations over 20 mg DON/kg induce vomiting (Bryden, 
2012). DON has a unique effect on immune system as it has the capacity to up and down 
regulate immune function depending on dose, exposure frequency, timing and the functional 
immune assay being employed (Pestka, 2008). The molecular mechanism of action of DON 
imply phosphorylation of mitogen-activated protein kinases (MAPKs) which in turn 
modulates expression of genes associated with immune response, inflammation and apoptosis. 
Leukocytes are among the most sensitive cells to DON effect as low concentration of this 
toxin upregulates immune and inflammatory genes and high concentration triggers cell death, 
typically by apoptosis, which leads to immunosuppression (Pestka et al., 2004). 
Immunosuppression engendered by DON has the potential to decrease resistance to infectious 
diseases (Oswald et al., 2005). Previous reports in mice have shown that DON could increase 
reovirus replication, a double stranded RNA virus, in enteric (Li et al., 2005) and respiratory 
(Li et al., 2007) infection models. In this latest model, DON exacerbated viral-induced 
inflammation and pulmonary damage by suppressing type-1 interferon (IFN) response and 
elevating expression of proinflammatory cytokines (Li et al., 2007). DON has also been shown 
to modulate the virulence-dependent pathogenesis of infectious bursal disease virus (IBDV) in 
infected broiler (Danicke et al., 2011). In that study, Fusarium contaminated diet, containing 
predominantly DON at 10.7 mg/kg of diet, significantly increased histopathological lesions of 
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IBDV infected birds. Previous report showed that oral administration of purified FB1 
significantly increased the severity of pulmonary lesions following porcine reproductive and 
respiratory syndrome virus (PRRSV) infection (Ramos et al., 2010). Up to date, no study has 
reported an interaction of DON with swine viral infections. However, our recent in vitro 
results showed that doses over 140 ng/mL of DON could inhibit PRRSV replication (Savard et 
al., 2014).   
Swine industry faces many diseases that threaten animal health and the economy of the 
industry. Among these diseases, PRRS represents the most economically important viral 
disease of swine industry in North America (Holtkamp et al., 2013). PRRSV causes common 
clinical signs such as anorexia, fever, and lethargy. In sows, PRRSV is responsible of 
reproductive failure, characterized by late-term abortions, increased numbers of stillborn 
fetuses, and/or premature, weak pigs. Furthermore, PRRSV is responsible of respiratory 
problems in growing and finishing pigs. Respiratory problems induce by PRRSV are usually 
more severe in young piglets and often aggravated by co-infections with bacterial and viral 
pathogens (Chand et al., 2012; Dorr et al., 2007). PRRSV is an enveloped, single stranded, 
positive sense RNA virus belonging to the Arteriviridae viral family, which includes lactate 
dehydrogenase-elevating virus (LDV) of mice, simian hemorrhagic fever virus (SHFV) and 
equine arteritis virus (EAV) (Meulenberg et al., 1994).  
Pigs are frequently exposed to DON because of their cereal-rich diet that is frequently 
contaminated by Fusarium spp. mycotoxins. Chronic exposure of pigs to DON could impair 
immunity and decrease resistance to infectious diseases, on the other hand in vitro exposure to 
DON could inhibit PRRSV replication. Therefore the objective of this study was to evaluate 
the impact of DON naturally contaminated feed on PRRSV in vivo infection.  
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2. Materials and Methods. 
2.1. Animals 
The experiment was conducted at the Faculté de médecine vétérinaire, Université de 
Montréal. Animal care procedures followed the guidelines of the Canadian Council on Animal 
Care and the protocol was approved by the Institutional Animal Care Committee (Protocol 
#11-Rech-1609). Thirty commercial crossbred piglets, negative for PRRSV were purchased 
locally at 4 weeks of age. After one week of acclimation on a commercial ration, piglets were 
randomly divided into 3 experimental groups of 10 animals, housed separately and fed 
naturally contaminated diets containing 0, 2.5 or 3.5 mg/kg of DON for all the duration of the 
experiment.  
2.2. Experimental diets 
Experimental diets (Table 1) were formulated according to the energy and amino acid 
requirements for piglets as previously described in the National Swine Nutrition Guide (2010). 
Wheat used in experimental diets was naturally contaminated with DON. Dietary contents of 
mycotoxins (Table 2) were analysed in the final diet through ultra-performance liquid 
chromatography/electrospray ionization tandem mass spectrometry, based on method of 
(Jackson et al., 2012).  
2.3. PRRSV challenge strain and experimental infection 
PRRSV isolate used in this study was FMV12-1425619 (GenBank accession number 
KJ888950), obtained from one serum sample originating from a PRRS clinical case. Based on 
ORF5 phylogenic analyses, this strain, often associated with clinical signs reported from the 
field, was classified within a lineage 1 of type II genotype cluster that is frequently found in 
Quebec over the past 2 years (data not shown). Since several different attempts to isolate the 
virus have failed, the viral inoculum was obtained from a lung tissue homogenate after 
infection of piglet with 3 mL of PRRSV positive serum, 2 mL intranasally (i.n) and 1 mL 
intramuscularly (i.m), containing 1.7 X 10
3
 TCID50/mL PRRSV. PRRSV concentration in 
filtrated lung tissue homogenate was determined by RT-qPCR to be 1.5 X 10
4
 TCID50/mL. It 
was also determined by PCR that the tissue homogenate was negative for bacteria (with a 16S 
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gene amplification by PCR) (Cai et al., 2003), swine influenza virus (Tremblay et al., 2011)  
porcine parvovirus (Gagnon et al., 2007)  and porcine circovirus (Gagnon et al., 2008). A pilot 
study using four animals confirmed the capacity of the virus containing inoculum to induce 
PRRSV-specific clinical signs, viremia, and lung lesions (data not shown). 
After 2 weeks on the experimental diets, all experimental groups were further 
subdivided in groups of 6 pigs, kept in separated rooms and inoculated i.m with 1mL 
containing 1.5x10
4
 TCID50 PRRSV and i.n with 1mL of the same inoculums in each nostril. 
Remaining pigs of each experimental groups (4) were housed separately and were sham-
inoculated with PBS buffer.  
2.4. Body weight, rectal temperature and blood collection. 
Pigs were daily monitored for rectal temperature, body weight and clinical signs for 21 
days p.i. The average daily gain (ADG) was calculated by subtracting the initial body weight 
of the final body weight and divided by the number of experimental days. Fever was defined 
as body temperature higher than 40˚C for two consecutive days. Blood samples were collected 
at days -1, 3, 6, 9, 14 and 21 p.i. and PRRSV viremia was evaluated by RT-qPCR and 
serological response by ELISA. Serum samples were stored frozen for further analysis. 
2.5. Macroscopic and microscopic lung lesions evaluation. 
Pigs were euthanized on day 21 p.i., and macroscopic lung lesion scores were recorded 
to estimate the percentage of lung affected by pneumonia (scores vary from 0 to 100%). Each 
lung lobe was assigned a percentage to reflect the approximate volume of the lobe on the 
entire lung, based on lung schematisation of (Sorensen et al., 2006). Lung samples and 
tracheobronchial lymph nodes were fixed in 10% neutral buffered formalin to evaluate 
specific microscopic lesions. Lung samples were collected to evaluate viral load and stored 
frozen until tested. Lung sections were scored for severity of interstitial pneumonia as follows 
0= normal, 1= mild, 2=moderate, 3= severe, 4= severe with alveolar disappearance. Presence 
of leucocytes, serum, or necrotic debris in alveolar exsudate were also scored as follows 
0=normal, 0.5 rare, 1= mild, 2= moderate, 3= important, and 4= severe. Finally lymphoid 
follicular hyperplasia were scored as follows 0=normal, 1=mild, 2=moderate, 3= severe.  
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2.6. PRRSV quantification  
Sera and lung homogenates were analyzed for the presence of PRRSV RNA using RT-
qPCR assay as described by (Gagnon et al., 2008). Lung tissues were weighed, an equal 
volume of PBS added to sample and tissues were homogenized before viral RNA isolation. 
QIAamp Viral RNA kit (Qiagen) was used to isolate viral RNA from serum samples and lung 
homogenates according to the manufacturer’s instructions. A commercial PRRSV RT-qPCR 
diagnostic kit (NextGen, Tetracore Inc., Gaithersburg, MD, USA) was used for PRRSV 
quantification as recommended by the manufacturer. The quantification of PRRSV was 
determined by comparing the sample results with a standard curve based on the amount of 
serially diluted PRRSV IAF-Klop reference strain produced in MARC-145 cells and titrated as 
TCID50/mL in the MARC-145-infected cell (Gagnon et al., 2008). The PRRSV RT-qPCR 
results were expressed in TCID50/mL of serum or gram of lung tissues.  
2.7. PRRSV specific antibodies 
Sera were assayed for virus-specific antibody by ELISA with the Herdchek PRRS X3 
diagnostic kits (IDEXX Laboratories, Portland, Maine, USA). Serum were diluted 1/40 in 
diluents supplied by the manufacturer and the assay was performed following the 
manufacturers' instructions. A sample-to-positive (S:P) ratio equal or greater than 0.4 was 
considered positive. 
2.8. Statistical analysis 
Results are expressed as the mean ± SEM. All statistical analyses were performed 
using GraphPad Prism software (version 5.03, GraphPad Prism software Inc., San Diego, CA). 
Data were statistically analysed using a one-way ANOVA with Dunnett’s multiple 
comparison test, using animal receiving control diet as control group. For the ADG data, 
noninfected versus infected animals were compared by applying Student′s unpaired ′t′ test, for 
each DON concentration. For viremia, lung viral load and microscopic lesions, pair-wise mean 
comparisons between control and DON treated animals were made using Student′s unpaired ′t′ 
test. P<0.05 was considered to reflect statistically significant differences.  
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3. Results 
3.1. Growth performance 
Results of growth performance showed that noninfected pigs had significantly higher 
ADG than PRRSV infected pigs (Fig. 1A) regardless of DON contamination of the diets. 
Severe growth retardation was observed following PRRSV infection suggesting a high degree 
of virulence associated to FMV12-1425619 strain used for the experimental infection. 
Contaminated diet with DON at 3.5 mg/kg decreased significantly (P<0.05) the ADG of 
noninfected group with a loss of approximately 19% of kg/day compared to uncontaminated 
noninfected group (Fig. 1A). Same level of contamination in infected animals had severe 
impact since they had a 40% of ADG less than PRRSV infected animals fed control diet 
(P<0.05) (Fig. 1A). These data suggest that pigs fed high mycotoxin diet are more affected by 
PRRSV than those fed uncontaminated diet, and the anorectic effect of DON could be additive 
to that of PRRSV infection. 
One PRRSV infected pig in control diet group and one PRRSV infected pig in 2.5-
mg/kg group were humanely sacrificed at day 16 and 17 p.i., respectively. At necropsy, lungs 
of both animals showed PRRSV associated lesions covering over 30% of the organ. At 
microscopic level, lungs section of both animals showed interstitial pneumonia with presence 
of leucocytes and necrotic debris in alveolar exudate. Two PRRSV infected pigs in 3.5-mg/kg 
group were found dead at day 12 and 20 p.i. Due to damage caused by post mortem freezing, 
the accurate assessment of PRRSV specific lesions has been made difficult. All data from 
these pigs were excluded from further analysis. Mortality rate due to infection was relatively 
high, being above 15% for all infected groups (Fig. 1B). Mortality in the PRRSV infected 
group ingesting 3.5 mg/kg of DON contaminated diet was at 33% but not statically significant, 
due to the small number of pigs included in the study. All non-infected pigs survived the 
experiment (data not shown).  
3.2. Body temperature, viremia and viral loads in the lungs. 
Five out of 6 PRRSV infected pigs fed uncontaminated diet and 4 out of 6 fed 2.5 
mg/kg diet had fever over 6 days (Fig. 2A). In contrast, no pig from PRRSV infected group 
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receiving diet contaminated at 3.5 mg/kg of DON experienced fever episode. Temperature of 
all noninfected animals remains normal for all duration of the study (Fig. 2B). All 
experimentally infected pigs, regardless of DON contamination levels of the diet, developed 
viremia from day 3 p.i. to the end of the experiment (Fig. 3A). Viremia was significantly 
higher in DON contaminated groups early after experimental infection at day 3 p.i. for 2.5 
mg/kg DON treated group and at day 6 p.i. for 3.5 mg/kg DON treated group suggesting an 
acceleration of viral replication kinetics in presence of DON (Fig. 3A). However, DON had a 
limited impact on viremia after day 9 p.i. since viremia was similar between all experimental 
groups (Fig. 3A). Evaluated at day 21 p.i., viral load in the lungs was also increased in all 
experimentally infected animals (Fig. 3B) compared to noninfected animals that were negative 
(data not shown). DON contamination appeared to be associated to PRRSV elimination in the 
lungs, since viral loads of this organ were respectively 5 and 6 times lower in pigs fed diet 2.5 
mg/kg (P=0.0965) and 3.5 mg/kg (P=0.0195) of DON than pigs receiving uncontaminated diet 
(Fig. 3B).  
3.3. Macroscopic and microscopic lesions 
Following necropsy, observations were made of the macroscopic lung lesions of each 
piglet. Extents of lesions were recorded as percentage of lungs affected by pneumonia. 
Macroscopic lesions were observed on most of the lungs of animals that survived the 
infection. The extent of lung lesions was significantly more important in animals fed 3.5 
mg/kg DON diets (Fig. 4A) than the other groups. No significant PRRSV-associated lung 
lesions were observed in noninfected animals (data not shown). Microscopically, lungs of all 
infected pigs showed a severe interstitial pneumonia. However, infected group fed 3.5 mg/kg 
DON had significantly higher presence of leucocytes, serum, and or necrotic debris in alveolar 
exsudate (Fig. 4B). Analysis of lymph nodes did not reveal significant changes (data not 
shown). 
3.4. Antibody response 
As demonstrated by measured specific antibodies against PRRSV in the serum, all 
experimentally infected animals, regardless of DON contamination, had seroconverted (Fig. 
5). In animals fed uncontaminated diet, humoral response was significantly lower (P<0.05) in 
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animals ingesting 2.5 mg/kg of DON but was similar to that of animals fed 3.5 mg/kg (Fig. 5). 
Noninfected animals did not PRRSV seroconverted.   
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4. Discussion.  
Mycotoxins are frequently detected in different sources of grains designated to animal 
feeding. Among these mycotoxins, DON is the one that draws the most attention because of its 
frequent occurrence at levels high enough to cause adverse effects, particularly in pigs. The 
main clinical effect of DON at lower dietary concentrations is anorexia and decreased weight 
gain (Danicke et al., 2004; Goyarts et al., 2005; Rotter et al., 1994). The reduced weight gain 
observed following ingestion of our experimental diets is consistent with what has been 
previously observed.  
In this study, growing young piglets have been used as a model for experimental 
infection with PRRSV that can cause many different clinical manifestations including fever, 
lethargy and severe pneumonia often complicated by concurrent bacterial infections (Done et 
al., 1996; Rossow, 1998). But this clinical picture is highly variable, ranging from mild 
subclinical infection to acute death of infected animals (Mengeling and Lager, 2000). Several 
factors can influence the severity of PRRSV infection including host genetics, management 
practices, environmental factors, concurrent bacterial infections and virus strain heterogeneity 
(Goldberg et al., 2000; Halbur et al., 1995; Halbur et al., 1996). Environmental factor such as 
the presence of DON in animals feed could impact on the severity of PRRS disease following 
an experimental infection. Like DON, PRRSV has been shown to cause anorexia and 
reduction of weight gain (Done et al., 1996; Rossow, 1998). Results of experimental infections 
showed that ingestion of diets highly contaminated with DON greatly increases the effect of 
PRRSV infection on reduction of weight gain. Both effect appears to be additive.  
Nonetheless, animals in this study were fed naturally contaminated diets. It is well 
known that Fusarium naturally infected cereals are commonly contaminated with low levels of 
several different mycotoxins (Binder et al., 2007). In this study, FB1 was the second most 
abundant mycotoxin found after DON. In swine, FB1 can have negative impact on production 
by causing pulmonary edema, liver failure or cardiovascular toxicity (Haschek et al., 2001). 
FB1 has also been shown to increase the severity of pulmonary lesions following porcine 
reproductive and respiratory syndrome virus (PRRSV) infection (Ramos et al., 2010). 
However, the FB1 concentrations found in our experimental diets are well below levels that 
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may cause clinical signs according to Ramos et al. (2010). However, we cannot exclude that 
they could, in part, be responsible for the observed effect. Co-occurrence of FB1 and DON in 
animal feedstuffs is common and it has been shown that subclinical co-exposure of pigs to 
these toxins resulted in greater immune suppression than exposure of a single toxin (Grenier 
and Oswald, 2011). A significant amount of DON was also found in a conjugated form of 
DON, the DON-3-glucoside. It is not surprising to found this form of conjugate because it was 
estimated that this conjugate could constitute up to 20% of the total content of its mycotoxin 
precursor (Berthiller et al., 2006). Hydrolysis of this conjugate, following ingestion, may thus 
increase exposure to the precursor toxin.  
In addition to anorexia, DON has also demonstrated a unique ability to up- and down-
regulate immune functions (Pestka et al., 2004). As consequence, DON has been shown to 
exacerbate some viral infection in mice (Li et al., 2007; Li et al., 2005) and in broiler chicken 
(Danicke et al., 2011). Here, results of the study showed an increase of viremia during the first 
days’ p.i. following chronic ingestion of DON. This suggests that DON could accelerate the 
kinetics of viral replication by an unknown mechanism. This result is in contradiction with our 
previous in vitro study showing that DON, at concentration over 140 ng/mL could inhibit 
PRRSV replication (Savard et al., 2014). This could be explained by the fact that in vivo 
exposure to DON in this study was not the same under in vitro conditions. Indeed, it was 
previously shown that the maximum blood level of DON was approximately 20 ng/mL 
following ingestion of contaminated diet at 4.5 mg / kg of DON (Goyarts and Danicke, 2006), 
this level similar to the highest contamination doses used in the present study, which is 
probably insufficient to have the DON inhibitory effect. However, the viremia was not 
modulated by DON, at the end of the viremic period, between days 9 and 21 p.i. Viral load in 
the lungs, observed at 21 days p.i. was significantly decreased by chronic consumption of 
DON. This suggests that virus elimination could be accelerated in the presence of DON. This 
is in contradiction with previous reports which reported an increased lung and intestinal 
reovirus burden and suppression of viral clearance in mice (Li et al., 2007). Unlike its effect 
on blood viremia, DON is more inhibitor on viral load in the lungs, which is in agreement with 
our previous study. PRRSV is responsible of specific lung lesions that vary from no apparent 
to severe tan consolidation lesions that are frequently aggravated by lesions resulting from 
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concurrent bacterial infection (Rossow, 1998). Here, PRRSV specific macroscopic lung 
lesions were significantly increased by the chronic absorption of DON, when present in larger 
quantity. Since lung viral load appears to be lower in DON exposed animals, the increased 
clinical effects in these groups could not be explain by increased viral replication. To some 
extent, the increased clinical and pathological effects of PRRSV can be caused by enhanced 
inflammatory immune response rather than the higher levels of virus replication (Morgan et 
al., 2013; van Reeth and Nauwynck, 2000). Since DON has been previously shown to 
stimulate the expression of pro-inflammatory cytokines in lungs of mice (Amuzie et al., 2008), 
excess production of pro-inflammatory cytokines following DON exposure can possibly 
explain the higher clinical and pathological effects seen in PRRSV infected animal fed high 
DON diet. Further investigations will be needed to confirm this hypothesis. Microscopically, 
PRRSV-specific lung lesions were characterized by septal thickening and presence of alveolar 
necrotic debris, macrophages and other mononuclear cells. Higher level of DON 
contamination significantly increases the presence of alveolar necrotic debris, macrophages 
and other mononuclear cells. These results are consistent with the previous hypothesis. 
PRRSV infections normally induce an abundant virus-specific antibody response with 
minimal virus neutralization activity (Kimman et al., 2009). Our results showed that dietary 
DON at 2.5 mg/kg significantly decreases PRRSV specific humoral responses. PRRSV 
vaccines are important tools in the effort to control the disease. Up to date many PRRSV 
vaccines have been developed, including products that contain modified live virus (MLV) 
derived from cell culture attenuation of virulent field isolates (e.g. Ingelvac® PRRS MLV and 
Porcilis® PRRS) (Murtaugh and Genzow, 2011). Presently, only MLV-PRRSV vaccines offer 
good protection towards homologous strains and mitigated efficiency against anti-genically 
distant heterologous isolates (Murtaugh and Genzow, 2011; Zuckermann et al., 2007). Here 
we showed some indication that immune response against virulent strain could be affected in 
presence of mycotoxins and that could potentially affect the efficiency of MLV vaccines. 
In conclusion, results of this study reveal that anorectic effect of DON is additive to 
anorectic effect of PRRSV, aggravating clinical signs of the infection, when ingested in higher 
concentration. At level frequently encounter in the field, anorectic effect of DON had more 
important impact than its inhibitor effect on PRRSV replication.  
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Figure 1 
 
Fig.1. Effect of DON naturally contaminated diets on piglet’s growth following PRRSV 
infection. 
Groups of piglets (10) were fed with DON naturally contaminated diets (2.5 and 3.5 mg/kg of 
feed) for 2 weeks. A control group of piglets received uncontaminated diet for the same period 
of time. A subgroup of piglets (n=6) was PRRSV infected and the remaining piglets (4) were 
sham infected with PBS. Average daily gain was calculated by dividing the total weight gain 
on the number of days of the study (A). Kaplan-Meier survival curve in infected animals with 
end points piglet death (B). 
+++
significant when compared to respective infected group 
(P<0.001).  
*
significant when compared to control group (0 mg DON/kg)  (P<0.05). 
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Figure 2 
 
 
Fig.2. Time course of body temperature (°C) during experimental infection. 
Infected (A) and noninfected (B) pigs were monitored daily for rectal body temperature during 
21 days p.i. Fever was defined as rectal temperature higher than 40˚C for two consecutive 
days. 
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Figure 3 
 
 
Fig.3. Effect of DON naturally contaminated diets on PRRSV viremia and viral load in the 
lungs. 
Blood was collected at day -1 3, 6, 9, 13, and 21 pi and serum tested for the presence of 
PRRSV RNA by RT-qPCR (A). At necropsy, sections of lung were collected to determine the 
pulmonary viral load by qPCR (B). Data are expressed in TCID50/ml. 
*
significant when 
compared to control group (0 mg DON/kg) at the same day (P<0.05). Note: animals died 
during the experiment were excluded from the analysis. 
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Figure 4 
 
 
Fig.4. Effect of DON naturally contaminated diets on macroscopic and microscopic lung 
lesions in PRRSV infected animals. 
At necropsy, on day 21 p.i., macroscopic lesions were recorded as percentage of affected 
pulmonary lobes (A) and microscopic presence of leucocytes, serum, or necrotic debris in 
alveolar exsudate were scored (B). 
*
significant when compared to control group (0 mg 
DON/kg) at the same day (P<0.05). Note: animals died during the experiment were excluded 
from the analysis. 
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Figure 5 
 
Fig.5. Effect of DON naturally contaminated diets on PRRSV specific antibody response. 
Blood was collected at day -1, 9, 13, and 21 p.i. and sera were tested for the presence of 
specific PRRSV antibodies using a commercial ELISA kit (Herdchek-PRRS®,IDEXX). Data 
are expressed in ratio of sample to positive. 
*
significant when compared to control group (0 
mg DON/kg) at the same day (P<0.05). 
#
tendency when compared to control group (0 mg 
DON/kg) at day 21 (P=0.09) 
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Table 1. Diet compositions.  
Ingredient 
g/kg diet 
Control diet  
(0 mg/kg DON) 
Diet #1 
(2.5 mg/kg DON) 
Diet # 2 
(3.5 mg/kg DON) 
Wheat (0 mg/kg DON) 713.35 543.35 389 
Wheat (9 mg/kg DON) 0 167 324.5 
Soybean meal 100 100 100 
Lactoserum 75 75 75 
Fat 15 15 15 
Phosphate Dical.-21% 12 12 12 
Limestone 12 15 12 
Salt 3 3 3 
Threonine 3 3 3 
Methionine 1.65 1.65 1.65 
Se mg/kg 0.4 0.4 0.4 
Vitamin E 10% 0.25 0.25 0.25 
Cu chloride 58% 0.15 0.15 0.15 
 
All diets were formulated to reach the following requirement: metabolisable energy 3200 
kcal/kg, protein 19%, fat 3%, fiber 2.5%, moisture 10%, Ca 0.8%, Mg 509 mg/Kg, total P 
0.7%, K 0.7%, Na 0.2%, Se 0.6 mg/Kg, Cu 120.4 mg/kg, Zn 250 mg/Kg, vitamin A 18.4 
KIU/Kg, vitamin D 2.5 KIU/Kg, vitamin E 106.7 mg/Kg, biotin, 0.3 mg/Kg.  
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Table 2. Mycotoxins’ content of the diets. 
     Diets  
Mycotoxin contamination (mg/kg)
a
 0 2.5 3.5 
Ochratoxin A 0.0043 N.D
b
 N.D 
Ochratoxin B 0.0028 N.D N.D 
Deoxynivalenol 0.2782 2.6680 3.7553 
3-AcDon N.D 0.0227 0.0220 
15-AcDon N.D N.D 0.0340 
DON-3-Glucoside 0.0134 0.1750 0.2732 
Fumonisin B1 0.4440 0.4596 0.4385 
Zearalenone N.D 0.2342 0.2091 
Mycophenolic Acid N.D 0.0033
c
 0.0021
c
 
Wortmannin N.D 0.0011
c
 N.D 
Verruculogen N.D N.D 0.0100 
Ergometrine/Ergonovine 0.0045 0.0020 0.0013
c
 
a
Value of detected mycotoxin in at least one diet only.  
b
N.D: Not detected, values below limit of detection.  
c
Values under the limit of quantitation but above limit of detection. 
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Presence of mycotoxins in animal feedstuffs is highly prevalent around the world 
(Griessler et al., 2010). In Canada, weather conditions, especially during the summer, favour 
mold growth and mycotoxins production in cereals intended for pig consumption (Johnston, 
2011). Fusarium toxins including T-2 toxin (T-2), zearalenone (ZEA), fumonisin B1 (FB1) 
and deoxynivalenol (DON) are the most frequently found. In fact, DON is a mycotoxin that is 
frequently detected and occurs in toxicologically relevant concentrations (Placinta et al., 
1999). It is capable of inducing acute and chronic toxic effects, depending on the level and 
duration of exposure as well as age and animal species. Indeed, pigs are considered the most 
sensitive farm animals to the effects of DON and many economic losses of swine industry are 
attributed to DON-contaminated feed that impact animal health. Clinical effects of DON 
contamination are well documented, but only few papers describe its involvement in disease 
susceptibility. Deoxynivalenol is known to produce immunomodulatory response depending 
on the dose and the duration of exposure. Low concentrations, averaging 1.57 mg/kg in a diet 
naturally contaminated and given for 22 days, decreased feed intake (9.1%) and average daily 
weight gain (5.2 %) in pigs (Johnston, 2011). Although, pigs may vomit at a high DON 
concentration of 20 mg/kg, it is more likely that they will refuse feed completely with 
concentrations over 12 mg/kg. These DON concentrations also promote a rapid onset of 
leukocyte apoptosis as an expression of immunosuppression (Bondy & Pestka, 2000; Young et 
al., 1983). Because of these effects and to limit the impact of DON-contaminated feed in the 
swine industry, recommendations in Canada and USA are less than 1 mg/kg of DON in feed 
intended for pig consumption (Johnston, 2011).  
Porcine reproductive and respiratory syndrome is one of the most economically 
important and devastating porcine viral disease worldwide (Neumann et al., 2005). The virus 
causing PRRS (PRRSV) was first isolated in the Netherlands using porcine alveolar 
macrophages (Wensvoort et al., 1991) and later in North America (Collins et al., 1992). It is 
an enveloped, single-stranded positive sense RNA virus, approximately 50–65 nm in diameter 
that is classified in the order Nidovirales, family Arteriviridae, genus Arterivirus (Benfield et 
al., 1992). The disease has many clinical manifestations in sows and piglets such as late-term 
abortions and an increased number of stillborns, mummified and weak born animals. The 
marked variation in the severity of PRRS is explained by several factors. These factors include 
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PRRS virus strain variation, the presence of other pathogens, age of the pig and stage of 
reproduction at the time of infection, level of immunity in the herd, herd size, housing, and 
environment (Thacker, 2003). 
 
This study aimed to evaluate the effect of DON on PRRSV replication in an in vitro 
model and to determine the impact of DON-naturally contaminated feed on PRRSV infection 
in piglets. 
 
In the first experiment, the effect of DON on porcine alveolar macrophages (PAM) 
(Wensvoort et al., 1991) and MA104-derived monkey kidney MARC-145 cells lines (Kim et 
al., 1993) was evaluated. These cells are known to be permissive to PRRSV infection and the 
virus induced a cytopathic effect (CPE) between 48h and 72h p.i. MARC-145 cells are an 
extensively used cell line in the studies of PRRSV host cell interactions including type I IFN 
and type II IFN antiviral mechanism (He et al., 2011). Porcine alveolar macrophages cells are 
the natural PRRSV host infected cells. These cells are phagocytes that play a critical role in 
homeostasis, host defense, response to foreign substances, and tissue remodeling (Gomez-
Laguna et al., 2012).  
Results of cell viability and mortality showed that the addition of DON alone at the 
concentration of 560 ng/mL and higher was significantly detrimental to the survival of 
MARC-145 and PAM cells (Fig. 1A and B in vitro model). Compared to MARC-145 cells, 
PAM cells showed greater sensitivity to DON, since concentrations over 280 ng/mL were 
significantly detrimental to their survival (Fig. 2B in vitro model). These results are in 
agreement with those obtained by Wan, et al. (2013) after treating IPEC-J2 intestinal cell line 
with 13 to 54 ng/mL of DON which reduced cell viability compared to control and thus 
confirmed the interactive cytotoxic effects of DON. More importantly, we have noted that 
exposition to DON at sub-toxic concentrations of 140 ng/mL significantly reduced cell 
mortality caused by PRRSV (Fig. 2A in vitro model).  
We also have determined PRRSV titers after MARC-145 cells and PAM cells were 
treated with increasing doses of DON. After 72h, virus titers gradually decreased, starting at 
140 ng/mL of DON in MARC-145 cells (Fig. 3A in vitro model) and PAM cells (Fig. 3B in 
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vitro model). Taken all together, these results suggest that DON could inhibits PRRSV 
replication in vitro, in a dose-dependent manner, which could explain the decrease in cell 
mortality produced by DON after PRRSV infection. 
 Previous studies have shown that DON mediates upregulation of mRNA expression of 
some pro-inflammatory and antiviral genes as well as apoptosis at high concentrations (Pestka, 
2010). Our results also showed an upregulation of IL-6, TNF-α and type I IFN (-α, -β) 
cytokines mRNA after exposition of the cells to DON at 1200 ng/mL for 3h (Fig.4 A, B, C 
and D in vitro model). This upregulation of  mRNA expression of some genes is probably due 
to the induction of transcription factors expression (c-Fos, Fra-2, c-Jun, JunB) that activate 
transcription factors (NF-κB, CREB, AP-1) which regulate expression of inflammation and 
immune related genes (Pestka, 2010; Zhou et al. 2005; Moon & Pestka 2002). The data also 
demonstrated that cells infected exposed to PRRSV suppressed the expression of type I IFN 
(Fig. 4 A, and B in vitro model) but not pro-inflammatory mRNA expression such as IL-6 and 
TNF-α (Fig. 4 C and D in vitro model). A previous study of Albina et al. (1998a) suggested 
that PRRSV evades innate immune response by interfering with type I IFN signaling pathways 
by the activation of the IFN-β promoter stimulator 1 (IPS-1) in the retinoic acid-inducible 
(RIG-1) signaling pathway (Luo et al., 2008) and by blocking the nuclear translocation of ISG 
factor 3 (ISGF3) (Patel et al., 2010). 
 High concentrations of DON are detrimental to cells and promote rapid onset of 
leukocyte apoptosis, which can be manifested in the form of immunosuppression (Bondy & 
Pestka, 2000; Pestka et al., 1994). Deoxynivalenol also has the capacity to activate 
mechanisms of action such as mitogen-activated protein kinase (MAPK) and extracellular 
signal-regulated protein kinases (ERK) to induce macrophages apoptosis and cytokine gene 
expression (Islam et al., 2006; Zhou et al., 2005). In our study, cells were in apoptosis after 3h 
and 6h DON exposition (Fig. 5 A and B in vitro model). Caspase-3 activation was 
significantly increased suggesting cell mortality by apoptosis at 6h p.i. (Fig. 5B) after 
exposure to the highest concentrations of DON (1200 ng/mL). It has been demonstrated that 
PRRSV can also induce apoptosis of PAM cells in the lungs and produces changes in the 
population of broncho-alveolar monocytes/macrophages, by the reduction of the well-
differentiated macrophages and the recruitment of new monocytes (Labarque et al., 2003; 
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Labarque et al., 2000). Our experiment did not show significant changes of caspase-3 
activation in PRRSV infected cells. However, cells exposed to DON at higher concentrations 
(1200 ng/mL) probably die by apoptosis as DON highly increased caspase-3 activity. Our in 
vitro study was the first model to report an inhibitory effect of DON on PRRSV replication 
In our second experiment, we have determined the impact of DON-naturally 
contaminated feed on PRRSV infection. Deoxynivalenol has been shown to down or 
upregulate the immune function against viral disease (Li et al., 2005, 2007) and induced lower 
weight gain and anorexia. Our experiment demonstrated that pigs infected with PRRSV and 
fed with the highest dietary concentration of DON (3.5 mg/kg) experienced significantly more 
severe clinical manifestation, a higher mortality rate,  and a reduced average daily gain (ADG) 
when compared to control group (Fig. 1 A and B in vivo model). The mechanism by which 
dietary DON exerts its effect in pigs is still largely unknown. It has been postulated that feed 
refusal behaviour may be related to an irritant action of DON on the mucous membranes of the 
upper gastrointestinal tract (Trenholm et al., 1994; Friend et al., 1982).  
The clinical course of PRRSV infection is highly variable. In our study, the 
experimental infection with PRRSV in growing pigs led to severe respiratory disease and 
fever which consisted in a substantial increase in mean body temperature, exceeding 40.0°C 
(Fig. 2A in vivo model). Five out of 6 PRRSV infected pigs fed with an uncontaminated diet 
and 4 out of 6 fed with DON concentrations of 2.5 mg/kg had fever for over 6 days. In 
contrast, no pig from the PRRSV infected group receiving the highest dietary concentration of 
DON (3.5 mg/kg) experienced a fever episode. No fever occurred in non-infected animals 
during the study (Fig. 2B in vivo model). Respiratory disease in pigs is one of the most 
important health concerns for swine producers and it was reported as the leading cause of 
mortality in nursery and grower-finisher units.  
 We also analyzed the time course of viremia. Normally, the course of a typical PRRSV 
infection is characterized by an acute viremia stage lasting approximately 4 weeks followed by 
low levels of viremia and eventual resolution (Wills et al., 2003). Virus replication occurred 
mainly in the lungs and also lymph nodes, spleen, placenta and umbilical cord (Duan et al., 
1997b). In our study, the results demonstrated that all PRRSV infected pigs fed with naturally 
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contaminated diet at concentrations of 2.5 mg/kg and 3.5 mg/kg, have developed viremia from 
day 3 to day 21 p.i., but was significantly higher at day 6 p.i. for the 3.5 mg/kg diet. The exact 
mechanism of DON to accelerate the kinetics of viral replication is unknown; however the 
viremia is not modulated by DON after day 9 p.i. (Fig.3 A). The results are in contradiction 
with in vitro model suggesting that DON at concentration over 140 ng/mL could inhibit 
PRRSV replication. This could be interpreted because in vivo model, animals were fed with a 
dietary concentration and was not the same using in vitro DON concentrations.  
However, DON had a limited impact later in the course of the infection. From day 10 
to day 21 p.i., viremia was not modulated by DON (Fig. 3A in vivo model). It was concluded 
that ingestion of DON-naturally contaminated diet at the concentration of 3.5 mg/kg at day 21 
p.i. could significantly decrease viral load in lungs. This suggests that the excretion of the 
virus could be accelerated with the presence of DON (Fig. 3B in vivo model). According to the 
above, we observed that ingestion of diets highly contaminated with DON increased greatly 
the effect of PRRSV infection on ADG, lung lesion and pig mortality, without increasing viral 
replication significantly.  
 It was demonstrated that the contamination with DON may potentiate respiratory 
disease and lung damage, but the severity of clinical manifestations depends on variables 
including age, type of managing system, infectious dose, pathogen virulence and immune 
status (Van Reeth et al., 2001; Segales et al., 1998). In the present study, PRRSV experimental 
infection has caused severe lung lesions with interstitial pneumonia. At day 21 p.i. all animals 
were sacrificed and macroscopic lesions were analysed. Lung lesions were observed in most 
animals that survived the experimental infection. DON-naturally contaminated diet at 3.5 
mg/kg has played an important role in potentiating / aggravating PRRSV clinical 
manifestation. It was also responsible for an increase in disease susceptibility and produced 
lung lesions. There is a possibility that these two agents (DON/PRRSV) besides bacterial 
contamination aggravated lung lesions but this hypothesis must be confirmed. In contrast, 
DON-naturally contaminated diet at 2.5 mg/kg had no significant impact on lung lesions and 
clinical manifestations (Fig. 4A in vivo model).  
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Microscopic lesions were also analyzed and are mainly characterized as 
bronchointerstitial pneumonia with lymphohistiocytic inflammation and accumulation of 
necrotic cells (Han et al. 2013; Halbur et al. 1995a). The histological lesions of PRRSV 
infected animals are mainly interstitial pneumonia that is characterized by septal thickening 
and presence of alveolar necrotic debris, macrophages and other mononuclear cells (Collins et 
al., 1996). All PRRSV infected pigs showed severe interstitial pneumonia with leucocytes 
infiltration, serum, and necrotic debris in alveolar exsudate (Fig. 4B in vivo model). However, 
the infected group fed with DON-naturally contaminated diet at 3.5 mg/kg had significantly 
higher presence of leucocytes, serum, and necrotic debris in alveolar exsudate. 
Porcine reproductive and respiratory syndrome virus infection induces early specific 
antibody response that does not have the capacity to neutralize the virus, showing an inability 
of the antibodies to protect the animal against PRRSV infection (Lopez & Osorio 2004). In a 
study by Murtaugh et al. (2002), after 4 weeks p.i. antibody concentration was able to 
neutralize PRRSV and was correlated with the reduction of the virus in the lung and peripheral 
blood. Regarding specific antibody response in our study, it was identified that all 
experimentally infected animals had seroconverted. Data showed also that pigs fed with DON-
naturally contaminated diets at 2.5 and 3.5 mg/kg had affected specific antibody response and 
decreased PRRSV-specific humoral response (Fig. 5 in vivo model). Presence of DON in the 
diet had a significant impact on humoral immunity and prevented the production of 
neutralizing antibodies. This has to be kept in mind, because DON could increase disease 
susceptibility and interfere with vaccination programs used against frequent virus infections in 
the Canadian pig industry. 
Deoxynivalenol can influence the susceptibility to viral infections. A study of mice fed 
with DON contaminated diet and infected with a respiratory double stranded RNA virus has 
shown that DON could increase reovirus replication and exacerbated viral inflammation and 
pulmonary damage by producing a significant reduction of IFN type 1 response. Besides, 
DON might impact host resistance against reovirus and produce pathological changes in lungs 
(Li et al., 2005 and 2007).  
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In our in vitro experiment, we can support the hypothesis that DON alters in vitro 
cells’ properties and affects PRRSV replication in permissive cell lines. We demonstrated that 
DON alters in vitro PAM and MARC-145 cells’ properties and affects PRRSV replication in a 
dose-dependent manner, which may explain the decrease in cell mortality following sub-toxic 
doses ranging from 140 and 280 ng/mL. However, when cells were exposed to high 
concentrations of DON (over 560 ng/mL), their properties were affected and they showed 
significant cytopathic effects and expressed antiviral IFN type I and pro-inflammatory genes 
(IL-6 and TNFα). PAM and MARC-145 cells exposed to lower concentrations of DON did not 
show a complete alteration of their properties or death as occurred in cells exposed to high 
concentrations of DON.  
In our in vivo experiment we can support the hypothesis that ingestion of DON 
contaminated feed affects growth performance and exacerbates PRRSV infection. 
Deoxynivalenol has been reported to produce anorexia and reduce weight gain, as well as 
influence the course of the infection by weakening the immune system (Pestka et al., 1987). In 
our experiment, we demonstrated that DON-naturally contaminated diet at 3.5 mg/kg affects 
growth performance and exacerbates PRRSV infection in pigs. It was also responsible for 
increasing disease susceptibility, aggravating the clinical signs and producing lung lesions.  
 Deoxynivalenol is commonly found in North American grains. When DON is ingested, 
it can severely affect immune system and predispose to disease susceptibility. For instance, no 
other study has hypothesized whether DON could alter immune response against other viruses 
that affect pigs. It will be interesting to investigate the inhibitory effect of DON and other 
mycotoxins on virus replication and the capacity to aggravate clinical signs. Also, the presence 
of DON could potentially modulate immunological parameters and could eventually affect the 
efficiency of vaccination programs. In this respect, DON was shown to affect humoral 
immune response, which could undermine vaccine efficacy. 
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VI. CONCLUSION 
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The in vitro experiment with PAM and MARC-145 cells represented a good model to 
study the interactions between PRRSV replication and DON exposure. Exposition to DON at 
560 ng/mL concentrations and higher, concomitant with infection with PRRSV was 
detrimental to these cell lines. The PRRSV strains used induced a rapid cell death, depending, 
however, on DON dose exposure. Sub-toxic concentrations of DON (140 ng/mL) reduced cell 
mortality triggered by PRRSV by inhibiting PRRSV replication. This in turn could explain the 
decreased cell mortality due to DON in infected cells. The induction of the pro-inflammatory 
genes and the activation of apoptosis after DON exposition in PAM and MARC-145 cells 
appear to be detrimental to PRRSV survival.  
The in vivo experiment demonstrated the capacity of DON-naturally contaminated diet, 
especially at the concentration of 3.5 mg/kg, to worsen the effects of PRRSV infection on 
weight loss, clinical manifestations, lung lesions and pig mortality without significantly 
increase in PRRSV replication. This study will contribute to a better understanding of the 
effects of DON on animal health and immune response to viral infection caused by PRRSV. 
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